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ABSTRACT
Gossypol is a naturally occurring, highly colored yellow pigment indigenous to
the small intercellular pigment glands of the cotton plant genus Gossypium, which is
proposed to be part of plant’s defense system. Gossypol is characterized by wide
contraceptive, antiviral, anticancer and antifungal properties. However, the relatively
high toxicity of gossypol precludes its application in medical therapy. For this reason
the syntheses and tests of gossypol derivatives, have been tried to enable their
application as drugs. In our study, gossypol based methylation, glycosylation and
nanoconjugate reactions were explored. The gossypol derivatives were all fully
characterized by NMR, MS, FT-IR, UV spectrometry, HPLC and X-ray
crystallography. Firstly, hexamethyl ethers of gossypol were synthesized, particularly,
existence of four tautomers of gossypol tetramethyl ethers were chromatographically
separated and confirmed. Gossypol exhibited the strongest antioxidant activity, while
its ethers only remained partial antioxidant activity due to their conjugated
naphthalene structure preserved in the derivatives. The result of alpha-amylase
inhibitory activities of gossypol and its methylated ethers showed that the gossypol’s
methylated ethers were the alpha-amylase inhibitors, while gossypol was the
alpha-amylase activator. Furthermore, it was found that anticancer activity of the
gossypol and its methylated ethers depended on the degree of methylation level of
gossypol. Secondly, novel glycosidic gossypol analogues were obtained by the
ultrasound-assisted

reaction

of

potassium
ii

salt

of

gossypol

with

3,

4,

6-tetra-O-acetyl-α-D-glucopyranosyl bromide under phase transfer catalytic condition.
The evaluation of anticancer, antitrypanosomal activities as well as cytotoxicity of
those novel glycosidic gossypol derivatives implied that 6, 7'-gossypol diglycosidic
tetraacetate (compound 8) could be developed into a potential pharmaceutical
candidate in the treatment of cancer since it exhibited powerful cancer cells inhibition
with significantly low cytotoxicity. In addition, 7, 7'-gossypol diglycosidic
tetraacetate (compound 7) and 6, 7'- gossypol diglycosidic tetraacetate (compound 8)
possess antitrypanosomal activity with LD50 value of 2.12 and 2.44 µM, respectively.
Finally, gossypol reacted with fullerene [60] in the presence of sarcosine through the
Prato reaction, resulting in some unexpected N-methylfulleropyrrolidines, and
different products in variable yields were obtained when choosing toluene or
chlorobenzene as reaction medium. During the reaction, gossypol decomposed into
benzaldehyde which was successfully detected as a new intermediate. In an in vitro
assay of NO radical induced apoptosis in 3T3L1 cells for the N-methyl-2,
2-dimethylfulleropyrrolidine (compound 14) showed dose dependent and stronger
radical scavenging activities than the parent fullerene.
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CHAPTER 1

LITERATURE REVIEW
1.1 Introduction

Gossypol is a yellowish pigment and natural toxin found in the seeds of cotton
plants (various Gossypium species). Its dimeric, bis-naphthalene structures are
derived from sesquiterpenes of the cadinane family. The cadinanes are formed in the
biogenetic cascade from the bisabolane intermediate by a series of putative 1, 2-shifts
and cyclization. Gossypol exists as two atropisomers due to restricted rotation about
the biaryl bond (Jung and Fahey, 1983; Cane, 1999).

CHO OH
HO
HO
H3C

OH CHO
OH
OH

CH3 H3C
CH3

H3C

CH3

Figure 1.1 Chemical structure of gossypol

1.2 Discovery
Gossypol was first isolated by Longmore in 1886 from soapstock obtained on
refining cold pressed cottonseed oil. Later, Marchlewski purified the chemical in 1899
1

by precipitating it from an ether solution using acetic acid to produce gossypol acetic
acid. After further isolation, the chemical was named gossypol because of its
originality from the vegetative family species gossypium and its polyphenolic
chemical nature. Although cottonseed is the most familiar and abundant source of
gossypol, the chemical has also been found in the bark and flowers of the tropic tree,
Thespesia popolinea, common to Africa, Asia and the Pacific Islands, and in certain
the members of the family Malvaceae (Varol et al., 2009). Okra, one of the staples of
New Orleans creole cooking, also is a member of the same family and was reported to
contain gossypol in its seeds (Hron et al., 2007). However, further careful evaluation
of the chemical by chromatographic methods revealed it was not gossypol, but a
degradation product of a reaction of hydroxylated unsaturated fatty acid triglycerides
with aniline used in the gossypol analysis (Hron et al., 2007). The chemical structure
of gossypol was first derived in 1938 by Adams and his students, who did extensive
studies on its properties and reactions, and published a series of articles about the
determination of the structure (Adams and Geissman, 1938). Twenty years later,
Edwards (1970) confirmed Adams’ structural formula by being the first to succeed in
total synthesis of gossypol. Because of gossypol’s uniqueness and challenging
chemistry, it has been studied by many researchers since its discovery.
1.3 Initial research interest
Gossypol in cotton plants can slow down the reproduction of the insects that eat
cotton bolls and seeds. This compound can also affect reproduction of mammals

2

(Saluja, 1988). Pressed cake of cotton seeds, a byproduct of the cotton industry, is
sometimes fed to livestocks with unintentional contraceptive effects. Nevertheless, the
most interest in gossypol derives from its activity as a contraceptive in human males.
For example, the effect of gossypol on human male fertility has been known in China
for many years. In 1929, a study of couples who used crude cottonseed oil for cooking
showed that they were smaller than average families. Later, researchers were
convinced that the oil affected male fertility. Eventually researchers isolated the
contraceptive compound gossypol from the cotton seed oil. This discovery led to large
scale testing of gossypol as a male contraceptive in China during the 1970s, which
involved over 8,000 men, and continued for over a decade. The researchers found that
men taking a daily gossypol pill had reliable contraception, but without significant
change in libido (Taylor et al., 1991). Meanwhile, the chemical gossypol was
confirmed to be able to affect the maturation and motility of sperm through
inactivation of the enzymes required for the sperm to fertilize the ova (Ueno et al.,
1988). The contraceptive effect appears to be associated with the (-)-isomer, while
toxic effects (cardiac toxicity in cattle) appear to be associated with the (+)-isomer
(Heywood et al., 1988). However, the studies revealed two serious flaws: disruption
of potassium uptake and incomplete reversibility. The large-scale trials of gossypol in
Chinese men showed an abnormally high rate of hypokalemia among subjects,
varying from 1-10% (Bi et al., 1981). Hypokalemia is characterized by low levels of
potassium in the blood. Since potassium is one of the key elements used by the
muscles and nerves to transmit signals, low blood potassium can cause fatigue,
muscle weakness and at its most extreme, paralysis. Hypokalemia is usually the result
of kidney malfunction, and can be caused by excessive consumption of diuretics. Also,

3

there is evidence that the incidence of hypokalemia depends on intake dosage of
potassium (Lohiya, 1990; Kumar, 1997). Therefore, Coutinho of Brazil (2002)
claimed that previous reports of hypokalemia were the result of “the Chinese diet,
which is poor in potassium, and not to the effect of gossypol on the kidneys.”
However, researchers are still full of questions of the observations on the effect of
gossypol on kidney. Several studies of gossypol as a contraceptive in male monkeys
tried to remedy potassium loss by giving the monkeys a daily potassium supplement,
but the treatment did not stop the monkeys from losing potassium, which made the
researchers believe that hypokalemia was an inevitable side effect, even though the
dose the monkeys received were higher than the equivalent dose given to men.
Regardless of gossypol’s possible causal relationship with hypokalemia,
researchers at the World Health Organization (WHO) have other concerns about side
effects due to natural toxicity. Therefore, some argue that this alone should disqualify
it from further study (Waites, 1998).

1.4 Toxicity
The toxicity of gossypol has been shown on the reproductive system, heart, liver,
and membranes. Besides, the compound exhibits both pro- and anti-oxidant behavior.
Electron transfer (ET) functionalities, present in gossypol and its metabolites,
comprise conjugated dicarbonyl, a quinone derivative, Schiff bases, and metal
complexes. The parent possesses a reduction potential favorable for in vivo ET.
Considerable evidence points out oxidative stress, formation of reactive oxygen
species, DNA scission, and redox cycling by ET in biosystems, have similar

4

mechanism of action as gossypol. In a study on the apoptotic effect of gossypol on
human lymphocytes, gossypol in a concentration of 20-50 mM could induce apoptosis
in human lymphocytes without causing necrosis through cytotoxic effects. The
combined use of steroid hormones (methyltestosterone and ethinyl estradiol) and
gossypol (low dose) in an antifertility study in rats showed that the steroid hormone
made the procedure of spermatogenesis slower, while low dose gossypol caused all
sperm to lose their activity in the epididymis. Both affect the process of
spermatogenesis from different endpoints and successfully induce infertility in the
short term. A low dose of gossypol not only executes antifertility function in the
epididymis, but also affects the quality of spermatozoal production in testis by
impacting the procedures of both acrosomal formation and spermatozoal elongation.
This assists in maintaining long term infertility (Kovacic, 2003).

1.5 Bioactivities

1.5.1 Antioxidant property
Gossypol is a polyphenolic compound from the viewpoint of its chemical
structure. Like many other phenolic chemicals, such as butylated hydroxytoluene
(BHT), coumaric acid, gallic acid, quercetin, myricetin, catechin, gallocatechin, etc.,
gossypol is an effective and potent natural antioxidant. For example, gossypol was
found to be able to protect carotene in vitro against preformed fat peroxides many
decades ago (Hove, 1944a,b). Hove confirmed that cottonseed products containing
5

gossypol could inhibit carotene destruction and rancidity development in vitro, and
gossypol could act as a carotene-protecting antioxidant in vivo. Gossypol has shown
potential in inhibiting rat liver microsomal peroxidation, which is caused by an
incubation with ferric/ascorbate (IC50< 0.1µM) (Laughton et al., 1989). Gossypol also
exhibited a significant positive effect on oil and biodiesel stability. With a
concentration of 0.1% gossypol, the oxidative stability indices (OSI) of cottonseed oil
biodiesel could increase to 17.2 hours from 4.15 hours at 110 oC (Fan et al., 2008).
In some cases, modification of the functional groups on gossypol may not affect
its original chemical and biological activities. For instance, the modification of
aldehydic groups on gossypol to form dianilinogossypol, of which the free carbonyl
groups were tied up by the anilido complex, did not decrease the antioxidant activity
of the free compound (Bickford et al., 1954; Hove, 1944) Bickford and coworkers
(1954) also found the other Schiff base-formed gossypol derivatives, gossypol-urea,
gossypol-aminobenzene-thiol, and gossypol-glycineindicates, have roughly equivalent
antioxidative ability to gossypol on a molar basis. Gossypol bis(piperinoethylimine)
and bis(morpholinoethylimine) also showed potent antioxidant action in human blood
serum and rat brain synaptosomes. At equal concentrations, these substances
suppressed the peroxidation of lipids in enzymatic and nonenzymatic systems
regarding the oxidation of rat liver microsomes (Dalimov et al., 1989).

6

On the contrary, in many other cases, the modification of phenolic hydroxyl
groups on gossypol could significantly decrease the “chemical” antioxidative abilities
regarding free radical scavenging activity, reducing power, and DNA damage
prevention activity (Wang et al., 2008), demonstrating that the hydroxyl groups are
critical for the antioxidative activities. For example, 6-methoxy gossypol exhibited a
similar free radical scavenging activity as 6, 6'-dimethoxy gossypol, but both
methylated derivatives of the gossypol possessed a weaker radical scavenging activity
than gossypol. The concentrations of 6-methoxy gossypol and 6, 6'-dimethoxy
gossypol needed to scavenge 50% of the free radicals in the test system were two-fold
higher than that of gossypol (about 16ppm vs. 8ppm). Although gossypol, 6-methoxy
gossypol, and 6,6'-dimethoxy gossypol all reduced ferric ions to ferrous ions in a
dose-dependent manner, gossypol again showed greater reducing power and higher
efficiency than 6-methoxy gossypol or 6,6'-dimethoxy gossypol. However, all three
test compounds showed much stronger reducing power than commercial antioxidant
butylated hydroxytoluene (BHT). For instance, 6,6'-dimethoxy gossypol at a
concentration of 10 ppm exhibited the same reducing power as BHT at a 100 ppm
concentration.

The relative capability of gossypol and its methylated derivatives to

prevent DNA damage caused by ultraviolet light and hydrogen peroxide was
consistent with the compounds’ antioxidant effects.

This suggests that gossypol’s

protection of DNA may occur partially by quenching free radicals, therefore
alleviating oxidative stress. A previous study (Li et al., 2000) also found that gossypol

7

demonstrated the ability, in a dose-dependent manner, to protect supercoiled plasmid
DNA from damage caused by exposure to Fe3+/ascorbate.
1.5.2 Anti-cancer activity
Gossypol is capable of inhibiting the growth of a variety of cancer cell lines
including breast, colon, prostate, and leukemia cells (Balci et al., 1999; Benz et al.,
1990; Huang et al., 2006; Zhang et al., 2003). These disruptions include inhibition of
cytoplasmic and mitochondrial enzymes involved in energy production (Ueno et al.,
1988) and uncoupling of oxidative phosphorylation (Flack et al., 1993; Abou-Donia
et al, 1974). In addition, depletion of cellular adenosine triphosphate (ATP) has been
demonstrated in cultured tumor cells (Keniry et al., 1989). Gossypol also inhibits key
nuclear enzymes responsible for DNA replication and repair, including DNA
polymerase α (Rosenberg et al., 1986) and topoisomerase II, and blocks DNA
synthesis in HeLa cells (Wang, 1984). Hou et al. (2004) found that gossypol at 50 µM
for 6 hours could induce apoptosis in human promyelocytic leukemia cells (HL-60)
(DNA fragmentation, poly(ADP) ribose polymerase cleavage), and also induce the
truncation of Bid protein, the loss of mitochondrial membrane potential, cytochrome c
release from mitochondria into cytosol, and activation of caspases-3, -8, and -9. At a
low dose of 5 µM, gossypol also could cause a significant elevation of caspases-3, -8
and -9, which resulted in cell apoptosis of human colon cancer cell line HCT 116
(Zhang et al., 2007). Recent studies on human leukemia U937 cells showed gossypol
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at >10 µM resulted in significant cell cytotoxicity and DNA fragmentation, induced
caspase-3 activation and poly (ADP) ribose polymerase cleavage. These properties
make gossypol a potential antineoplastic agent.
It is reported that inhibition of DNA synthesis can be achieved with 10 µM
gossypol by blocking the G1/S checkpoint in MCF-7 cells at 24 hours of incubation
(Ligueros et al., 1997). Gossypol might regulate cell cycles by modulating the
expression of cell cycle regulatory proteins Rb and cyclin D1 and the phosphorylation
of Rb protein. Jiang et al. (2004) obtained a similar conclusion that inhibitory effect of
gossypol on the proliferation of human prostate cancer PC3 cells was associated with
induction of TGF-β1, which in turn influenced the expression of the cell
cycle-regulatory protein, cyclin D1. In human alveolar lung cancer cells, gossypol
induced Fas/Fas ligand mediated apoptosis (Moon et al., 2008a). Also, gossypol
induced transcriptional downregulation and posttranslational modification of hTERT
in human leukemia cells, causing inactivation of c-Myc and Akt, respectively. Both
c-Myc and Akt are able to regulate various Bcl-2 proteins, the pro-apoptosis protein
family members.
Gossypol also downregulates the expression of NF-kappaB-regulated gene
products, including inhibitors of apoptosis such as protein (IAP)-1, IAP-2, and
X-linked IAP. These results suggest that gossypol-induced apoptosis partially
involves suppression of NF-kappaB activity (Moon et al., 2008b). Treatment of
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Ramos cells with gossypol not only induced cell arrest on the G0/G1 phase, but also
increased apoptosis and growth inhibition induced by etoposide, doxorubicin
hydrochloride, vincristine, and paclitaxel (Li et al., 2008). Liu et al., (2002) found that
(-)-gossypol was more active in inhibiting breast cancerous epithelial cells and
cancerous stromal cells. Meanwhile, the inhibitory activity of (-)-gossypol was related
to the reduction of the cell cycle regulator, cyclin D1, and the induction of the cell
proliferation inhibitor, TGF-β.

In the study of human prostate cancer cells, it was

found that (-)-gossypol-induced apoptosis was mediated by the regulation of Bcl-2
and caspase families (Huang et al., 2006). Another in vitro study (Mohammad et al.,
2005) demonstrated (-)-gossypol had significant inhibitive effects against the growth
of lymphoma cell line WSU-DLCL2 and fresh cells obtained from a lymphoma
patient with no effect on normal peripheral blood lymphocytes. (-)-Gossypol also
induced complete cytochrome c release from mitochondria, increased caspases-3 and
-9 activity, and caused apoptotic death without affecting protein levels of Bcl-2,
Bcl-X (L), Bax, and Bak.

Recent research has revealed that (-)-gossypol acts as a

BH3 mimetic, binding to the BH3-binding domain in various pro-apoptotic proteins
of the Bcl-2 family, displacing pro-death partners to induce apoptosis (Balakrishnan et
al., 2008; Meng et al., 2008).
Sikora et al. (2008) found that the combination of gossypol with the antioxidant
N-acetyl-cysteine to block reactive oxygen species (ROS) would increase the (-)
gossypol-induced cytotoxicity in tumor cells, but not normal cells, indicating that
10

concurrent treatment with antioxidants to block ROS prevents oxidative inactivation
of

(-)-gossypol

and

limits

off-target

toxicity

allowing

more

potent

(-)-gossypol-induced anti-tumor activity. An in vivo study also showed that
(-)-gossypol significantly enhanced the antitumor activity of X-ray irradiation, leading
to tumor regression in the combination therapy by inhibiting both antiapoptotic
proteins Bcl-2 and/or Bcl-xL (Xu, 2005). A combination of docetaxel and
(-)-gossypol synergistically enhanced the antitumor activity of docetaxel both in vitro
and in vivo in the human prostate cancer PC-3 xenograft model in nude mice.
(-)-Gossypol exerts its antitumor activity through inhibition of the anti-apoptotic
protein Bcl-xL accompanied by an increase of pro-apoptotic Noxa and Meng et al.,
2008). One study on gossypol derivatives (Arnold et al., 2008)) showed that
apogossypolone could inhibit the growth of the lymphoma cell line WSU-FSCCL
with an IC50 of 109 nM, and the activation of caspases-9, -3, and -8 was observed.
Hu et al. (2008) found that apogossypol selectively inhibited proliferation of three
NPC cell lines (C666-1, CNE-1 and CNE-2) that highly expressed the anti-apoptotic
Bcl-2 proteins with release of cytochrome c, activation of caspases-9 and -3, and
apoptosis of sensitive NPC cells. The toxicity and efficacy study on mice (Kitada et
al., 2008) showed that mice tolerate doses of apogossypol 2- to 4-times higher than
gossypol. Apogossypol displayed superior activity to gossypol in terms of reducing
splenomegaly and reducing B-cell counts in the spleens of Bcl-2-transgenic mice,
indicating the potential of gossypol derivatives for cancer therapy. Gossypolone was
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less potent than gossypol in inhibiting human breast cancer cells (Gilbert et al., 1995).
The reduced effectiveness of gossypolone compared to gossypol in breast cancer cells
agrees with the antifertility effects (Kim et al., 1984), but is in contrast to the
antisteroidogenic and antireproductive effects of gossypolone, which have shown
similar potency as gossypol (Gu, 1991). Methylated gossypol, 6-methoxy gossypol,
and 6, 6'-dimethoxy gossypol, compared with the parent compound, showed superior
anti-cancer activity against cervical, breast, and colon cancer cells (Wang et al.,
2008).
In summary, gossypol is believed to arrest cell growth at the G0/G1 phase and
induce cell apoptosis, in cancer cells, by regulating the cell cycle, enzymes,
anti-apoptosis, and pro-apoptosis proteins.
1.5.3 Anti-virus activity
Lin et al. (1989 and 1993) reported that gossypol inhibited the replication of
human immunodeficiency virus-type 1 (HIV-1) and found (-)-gossypol to be more
inhibitory (IC50=5.2 µM) compared to the (+)-gossypol (IC50=50.7µM). Besides
HIV-1, gossypol also showed anti-viral activity in multiple enveloped viruses
including herpes simplex virus type 2 (HSV-II), influenza virus, and parainfluenza
virus (Vander Jagt et al., 2000).

12

Gossypol and a series of peri-acylated gossylic nitriles were compared for their
anti-viral activities against HSV-II and for their toxicities to the host Vero cells. All of
the peri-acylated gossylic nitriles exhibited lower cytotoxicities to the host cell than
did the parent compound gossypol. Both gossypol and the series of derivatives
exhibited anti-viral activities against HSV-II when the virus was treated with
concentrations as low as 5x10-7 M. Two of the derivatives, gossylic nitrile-1,
1'-diacetate and gossylic nitrile-1, 1'-divalerate, were capable of inhibiting viral
multiplication in Vero cells that were infected with virus before administration of the
drug. The authors (Radloff et al., 1986) concluded that modification of gossypol’s
aldehydic groups lowered its toxicity to the host Vero cells but did not abolish the
compound’s anti-viral (HSV-II) activity. Derivatives of gossypol may be useful as
anti-viral agents.
Later, Royer et al. (1991) found that gossypol and its derivatives, gossylic
nitrile-1, 1'-diacetate, gossylic iminolactone, and gossylic lactone inhibited the
replication of human immunodeficiency virus type 1 in vitro. Gossylic iminolactone
displayed the greatest inhibition, followed by gossypol, gossylic nitrile-1,
1’-diacetate, and gossylic lactone, indicating that derivatives of gossypol can retain
anti-viral activities. Then, Royer and coworkers (1995) tested several other gossypol
derivatives for inhibition of HIV: 1, 1'-Dideoxygossypol, 1, 1'-dideoxygossylic acid
(DDGA), 8-deoxyhemi -gossypol (DHG), and 8-deoxyhemigossylic acid (DHGA).
The result showed that DDGA was the most effective in inhibiting the replication of
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HIV in vitro with EC50 < 1 µM. Meanwhile, DDG was less effective than DDGA.
DHG showed some anti-HIV activity, and DHGA was ineffective against HIV. Since
all four gossypol derivatives were found to have much lower affinities for albumin
than the parent compound gossypol, this would possibly enhance the anti-virus
activity of the gossypol derivatives in vivo with less interference from in vivo proteins.
1.5.4 Anti-parasiticprotozoan activities
Malaria is a vector-borne infectious disease caused by protozoan parasites.
Human malaria is usually caused by the infection of Plasmodium falciparum,
Plasmodium malariae, Plasmodium ovale, and Plasmodium vivax (Mendis, 2001). It
is widespread in tropical and subtropical regions, including Asia, Africa and parts of
the Americas. Each year there are about 350-500 million cases of malaria, and more
than one million people die (CDC, 2009). A series of gossypol derivatives with
modified aldehydic groups and hydroxyl groups have been shown to inhibit the
growth of Plasmodium falciparum (Razakantoanina et al., 2000; Royer et al., 1986).
The derivatives with ethyl, propyl, or isopropyl side chains as well as gossylic nitrile
1,1’-divalerate with IC50 values close to gossypol (IC50=16 µM) showed stronger
inhibition than other gossypol derivatives against the growth of Plasmodium
falciparum.
Royer et al. (1986) proposed that the antimalarial activity of gossypol and
gossypol derivatives was through the inhibition of lactate dehydrogenase, which is the
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most active and essential enzyme for anaerobic life cycle of Plasmodium falciparum.
Any compound showing inhibition of this enzyme also kills the parasites
(Razakantoanina et al., 2000; Royer et al., 1986). Similarly, the inhibition of LDH
activity in T. gondii can also inhibit growth of the parasite in cultures (Dando et al.,
2001). In the study on Entamoeba histolytica (Gonzalez-Garza et al., 1993a and
1993b), gossypol also showed the inhibition to alcohol dehydrogenase and malic
enzymes, and (-)-gossypol was found more active than racemic gossypol and
(+)-gossypol. The (-)-gossypol was 3.6 and 13.0 times more potent than
(+/-)-gossypol and (+)-gossypol, respectively, in inhibiting the malic enzyme, and 1.9
times and 2.9 times more potent than (+/-)-gossypol and (+)-gossypol, respectively,
against the alcohol dehydrogenase.
Trypanosomes, protozoan parasites belonging to the subphylum Mastigophora,
can cause a chronic infection called sleeping sickness. It has seriously affected the
health of people in western and central African countries, and exerted significant
mortality in man and livestock. Over 60 million people living in 36 sub-Saharan
countries are threatened by sleeping sickness (WHO, 2001) and 48000 deaths were
reported in 2002 (WHO, 2004). In addition, 46 million cattle are exposed to the risk
of the sleeping disease. The disease costs an estimated 1,340 million USD per year
(Kristjanson, 1999). However, few drugs are available for the treatment of
trypanosomal infections that cause significant mortality in man and livestock in
Africa. Gossypol was reported to be able to inhibit trypanosomes (Blanco et al., 1983;
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Kaminsky and Zweygarth, 1989; Montamat et al., 1982). Montamat and coworkers
(1982) reported that a 5-min exposure to 100 µM gossypol (~50 ppm) immobilizes
cultures of Trypanosoma cruzi.

Blanco et al. (1983) reported that a 30-min exposure

to 25 µM gossypol (~12 ppm) immobilizes and alters the cell morphology of T. cruzi.
Later, Kaminsky and Zweygarth (1989) reported that, for three separate Trypanosoma
brucei strains (including one drug resistant strain), the IC50 value for a 24h gossypol
exposure was >10 ppm.

Our study showed a similar level of gossypol’s

anti-trypanosomal activity with IC50 value of 7.8 ppm after 24-h exposure.
Moreover, methylated gossypol, both 6-methoxy gossypol (IC50 value, 3.98 ppm) and
6, 6’-dimethoxy gossypol (IC50 value, 3.21 ppm) showed more effective inhibition of
growth than gossypol.

In the study of T. cruzi, gossypol was also reported to inhibit

some oxidoreductases (Gerez de Burgos et al., 1984; Montamat et al., 1982), such as,
alpha-hydroxyacid and malate dehydrogenases, NAD-linked enzymes, and glutamate
dehydrogenase, glucose-6-phosphate dehydrogenase, and NADP-dependent enzymes.
Gossypol also inhibits the MDH enzyme of T. cruzi (Gerez de Burgos et al., 1984).
Accordingly, the possible mechanism of the antiparasitic effect of gossypol and
gossypol derivatives could be the selective inhibition of vital enzymes in the parasites.
1.5.5 Anti-microbial activity
The anti-microbial properties of gossypol have been reported by several research
groups. Gossypol has general antifungal activities with LD50 values from 20 to 100
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ppm of pure gossypol (Bell, 1967), and has an inhibitory effect on microorganisms
including aerobic sporeformers and lactobacilli and some yeasts (Margalith, 1967).
Gossypol showed strong antibiotic activity against aerobic sporeformers and
lactobacilli, and displayed antagonistic property to some of the more oxidative yeasts.
Later, Vadehra et al. (1985) investigated the effects of gossypol on the growth of
a variety of bacteria and on spore formation and germination in Bacillus cereus. It
was found that gossypol had more potent antibacterial properties against gram
positive organisms (i.e. Streptococcus spp., Bacillus spp., Staphylococcus aureus)
than gram negative bacteria such as Pseudomonas aeruginosa, Salmonella spp.,
Klebsiella pneumoniae, Shigella spp., Proteus spp., and Escherichia coli. All of the
gram positive organisms tested were completely inhibited at a concentration of 100
ppm. None of the tested gram negative strains was inhibited at 100 ppm of gossypol,
and only 1/3 of the tested strains were inhibited at 200 ppm of gossypol. The authors
proposed that the anti-bacterial activity of gossypol was related to the gram character
of the organisms. Besides, the chemical and quantitative differences of the cell wall
and cell membrane of the gram positive and negative groups may influence the
transport of gossypol to its target site (i.e., Gram-positive organisms have high
amount of peptidoglycan in the cell wall, and lack the outer membrane found in
Gram-negative bacteria). The same research group also found that yeasts, such as
Saccharomyces cereviseae, S. uvarum, S. diasticu) were sensitive to gossypol, and the
growth were completely inhibited at 50 ppm of gossypol.
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Subsequent research

(Poprawski and Jones, 2001) found that fungi Paecilomyces fumosoroseus (associated
with cutaneous and disseminated infections in dogs and cats) were highly tolerant to
gossypol even at 500 ppm, but could be strongly inhibited at 1000 ppm of gossypol.
1.5.6 Lowering plasma cholesterol levels

Cholesterol is a fat-soluble compound found in the body. Having high "bad"
cholesterol means you have too much low density lipoprotein (LDL) in your blood,
which is linked to serious problems, such as atherosclerosis and coronary heart attack
or stroke. A study on adult male cynomolgus monkeys (Shandilya and Clarkson, 1982)
found that gossypol administered orally at 10 mg/kg/day for 6 months could cause a
significant decrease in total plasma cholesterol (TPC) and LDL without any
significant decrease in plasma high density lipoprotein cholesterol (HDL) levels.

It

was proposed that this cholesterol lowering activity might be attributed to: (a)
gossypol might possibly reduce the intestinal absorption of dietary cholesterol; and (b)
gossypol might reduce the hepatic synthesis of low density lipoproteins.

Studies

with rabbits also showed that dietary cottonseed protein effectively lowered the
concentration of plasma cholesterol when compared to the animal protein casein,
which was attributed to the presence of gossypol in the cottonseed protein. Thrice
weekly subcutaneous injection doses of 20 mg/kg body weight to rats for 4 weeks also
resulted in lower serum cholesterol. Another study on rats demonstrated that gossypol
consumption not only had a significant effect on alcohol dehydrogenase, but also a
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profound influence on the regulation of cholesterol level in the liver. A subsequent
study on rats showed that the administration of gossypol at 20 mg/kg body
weight/rat/day for 8 weeks could significantly decrease the serum level of cholesterol
in both low and normal protein-fed male Wistar rats. The combined administration of
gossypol and chloroquine (chloroquine, a 4-aminoquinoline, used for treatment of
malaria) to the protein-malnourished rats had more profound effects in decreasing the
levels of serum cholesterol and triglycerides compared to normal-protein fed rats,
indicating the implication of the treatment and dietary effect on the level of serum
cholesterol. However the mechanism by which gossypol lowers the serum cholesterol
still needs further investigation.
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CHAPTER 2

CHEMICAL CHARACTERIZATION AND BIOACTIVITIES OF GOSSYPOL
AND ITS METHYLATED ETHERS
2.1 Abstract
Tetramethyl and hexamethyl ethers of gossypol were synthesized from gossypol
that was extracted from cotton plant. The gossypol ethers were fully characterized by
NMR, MS, and HPLC methods. Particularly, existence of four tautomers of gossypol
tetramethyl ethers were chromatographically separated and confirmed by the
combination of NMR and LC/MS. Antioxidant activity in terms of DPPH free radical
scavenging capability of gossypol and its methyl ethers were compared. Gossypol
exhibited the strongest antioxidant activity, while its ethers only remained partial
antioxidant activity due to their conjugated naphthalene structure preserved in the
derivatives. In addition, alpha-amylase inhibitory activities of gossypol and its
methylated ethers were determined. The result showed that the gossypol’s methylated
ethers were the alpha-amylase inhibitors, while gossypol was the alpha-amylase
activator. Furthermore, it was found that anticancer activity of the gossypol and its
methylated ethers against MCF-7 cancer cells depended on the degree of methylation
level of gossypol.
2.2 Introduction
Gossypol is a polyphenolic aldehyde isolated from the members of various
Gossypium species, which is a natural toxin present in the cotton plant that protects it
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from insect damage (Smith et al., 1972). Gossypol exists as two atropisomers due to
the restricted rotation of its binaphthyl bond (Figure 2.1). As we mentioned in
Chapter 1, the initial research interest on gossypol derived from the (-)-gossypol
isomer that is active in male sterility discovered in in 1970s when it was found to be
able to affect the maturation and motility of sperm, and inactivate the enzymes
required for the sperm to fertilize the ova (Anonymous, 1978; Anonymous, 1980). In
addition, a number of potential biological activities of gossypol, such as antiviral
(Radloff et al., 1986; Lin et al., 1993), antiamoebic (Gonzalez-Garza et al., 1991), and
antiprotozoan effects (Blanco, et al., 1983; Gerez de Burgos, et al., 1984; Montamat et
al., 1982), were reported. While gossypol displays a certain degree of toxicity due to
its aldehyde groups which can easily bind nucleophilic targets of biological
importance (Clark et al., 1927; DePeyster et al., 1993; Gallup et al., 1931), various
gossypol derivatives such as apogossypol (Clark et al., 1928; Meltzer et al., 1985; Zhu
et al., 1992), gossypolone (Haas et al., 1965), gossypol ethers (Adams and Geissman,
1938; Adams et al., 1938; Datta et al., 1972; Haar et al., 1952; Morris et al., 1937;
Seshadri et al., 1973; Seshadri et al., 1975) and gossypol Schiff base (Dao et al., 2000;
Liang et al., 1995; Kim et al., 1987; Przybylski et al., 2003; Zheng et al., 1992), which
have been prepared since 1930s, have not been studied thoroughly for their
bioactivities. This prompted us to synthesize some of these gossypol derivatives, and
explore their novel bioactivities.
In this study, we synthesized, separated and fully characterized gossypol
tetramethyl ethers, hexamethyl ether and their tautomers.

In addition, their DPPH

free radical scavenging activities, alpha-amalyse inhibitory activities and anticancer
activities were determined.
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2.3 Experimental
2.3.1 Material
Structures of gossypol and all of its tested derivatives are shown in Figure 2.2.
2′-Bi [8-formyl-1, 6, 7-trihydroxy-5-isopropyl-3-methylnaphthalene]) acetic acid (1,
gossypol acetic acid, MW=578.6, C30H30O8•C2H4O2, HPLC purity >95%, racemic
form) was purchased from Zhejiang Yixin Pharmaceutical Co., Ltd. P. R. China.
6-Methoxygossypol (5) and 6, 6′-dimethoxygossytpol (6) (see Figure 2.2) were
isolated as previously reported (Kim et al., 1987). Racemic gossypol and possible
derivatives were biologically tested. 1, 1-diphenyl-2-picrylhydrazyl (DPPH free
radicals), butylated hydroxytoluene (BHT), 3, 5-dinitrosalicylic acid (98%) (DNSA),
alpha-amylase (type VI-B: from porcine pancreas), dimethyl sulfoxide (DMSO),
potassium carbonate (K2CO3), and phosphoric acid (H3PO4) were purchased from
Sigma Chemical Co., (St. Louis, MO). Starch from potatoes ((C6H10O5)n, Mr=162.14 n)
was purchased from Fluka, Germany. Potassium sodium tartrate (KNaC4H4O6•4H2O,
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FW=282.231), and sodium hydroxide were purchased from J. T. Baker Chemical Co.
(Phillipsburg, N.J. USA). Sodium phosphate (Na2HPO4, FW=141.96) and sodium
chloride were purchased from Fisher Scientific Company (Fair lawn, N.J. USA).
Iodomethane (CH3I 99.5% pure, 2.2789 g cm-3 at 20°C, molar mass 141.94 g mol-1),
and dimethyl sulfate ((CH3O)2SO2, d=1.33 g ml-1, molar mass 126.13 g mol-1) were
from Alfa Aesar company (Ward Hill, MA, USA). All solvents for chromatographic
isolation were of analytical grade. HPLC grade methanol, dichloromethane, acetone,
acetonitrile, and chloroform were purchased from Fisher Scientific Company (Fair
lawn, N.J. USA). Tissue culture plates were purchased from Costar Corp.
(Cambridge, MA). Heat-inactivated fetal bovine serum, fetal bovine serum, and
newborn calf serum were purchased from Hyclone Laboratories, Inc. (Logan, UT).
MCF-7 (human breast cancer) cancer cell lines were purchased from the American
Type Culture Collection (ATCC) (Rockville, MD).

2.3.2 Instruments for Chemical Analysis
HPLC analysis was carried out on a Shimadzu HPLC system that included
LC-20AT solvent delivery pumps, a CBM-20A communication bus module, a
SPD-M20A photo-diode array detector, and the ClassVP operating software. The
HPLC was equipped with a Kromasil RP C18 column (particle size of 5µm, column
size of 150 mm×4.6 mm, Alltech Associates, Inc. Deerfield, IL), which was placed in
a column oven (CTO-20A) under a constant temperature at 25oC. The mobile phase
consisted of methanol: H2O = 87:13 (v/v) containing 0.1% aqueous H3PO4. The
column flow rate was set at 1 ml min-1, while the HPLC pressure was controlled
between 1020-1040 psi.
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LC/MS analysis was performed on an Agilent 6100 series LC/MS in which a
quadruple mass spectrometer was coupled to an Agilent 1200 HPLC that consisted of
a G1329A high performance autosampler (hp-ALS-SL), a G1312A binary pump
(BIN-SL), a G1379B vacuum degasser, a G1316A thermostatted column
compartment (TCC-SL) and a G1314B variable wavelength detector (VWD-SL). The
quadrupole mass spectrometer was operated with an atmospheric pressure
electrospray ionization (API-ES) source in positive mode. The flow rate of HPLC was
maintained at 1 mL min-1 through a Kromasil RP C18 column (particle size of 5 µm,
column size of 150 mm×4.6 mm, Alltech Associates, Inc. Deerfield, IL). The mobile
phase in an isocratic elution consisted of methanol and water (v/v=87:13) containing
0.1% formic acid. Mass spectra were recorded within the m/z range of 100-1000. The
dry gas flow for MS was 13.0 L min-1, the nebulizer pressure was 30 psig, dry gas
temperature was 350ºC, and the Vcap voltage was 3500 V. Data was acquired from
and processed by the Agilent LC/MSD ChemStation software.
Some mass spectrum were obtained by a nanoflow capillary HPLC coupled with a
quadrupole time-of-flight micro mass spectrometer (Q-TOF-MS) (Waters Corp.,
Milford, MS) with an electrospray ionization (ESI) in both ESI-MS and ESI-MS-MS
modes operated by the Masslynx software (V4.0, Waters Corp., Milford, MS). Each
separated and purified sample was directly injected from the sample vial into the ESI
source in methanol at a flow rate of 1.5 µL min-1. The ion source voltages were set at
±3000V for positive and negative ion mode acquisitions, respectively. In both modes,
the source temperature was maintained at 100°C and the mass spectrum was scanned
from 100 to 800 m/z at 1 second with 0.1-second inter-scan delay in continuum mode.
For

MS/MS

analysis,

mass

spectrum
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was

scanned

from

50-800

m/z.

Glu-fibrinopeptide (Sigma) as a mass standard in ESI-MS and ESI-MS-MS mode was
infused through the nanoLockspray (Waters Corp., Milford, MS) for single point, real
time, and accurate mass calibration. Raw spectra were processed using the MassLynx
software (V4.0).

Precursor ion scans on positive and negative ion modes using low

energy collision induced dissociation (CID) resulted in more structural fragments,
which helped structural identification of compounds of interest.
1D and 2D NMR (1H NMR,

13

C NMR, DEPT, HMQC, HMBC) spectra were

acquired from a Bruker AV-500 spectrometer or JEOL operated at 300 MHz for 1H
NMR and 75 MHz for

13

C NMR. Data were processed by the Bruker XWINNMR

3.50 programs.
In addition, thin layer chromatography (TLC) analysis was performed on F254 plates
precoated with silica gel 60 and fluorescent reagent (Merck, Darmstadt, Germany).
The TLC was visualized at 254 nm in a UV-viewing system purchased from Fisher
Biotech.

Silica gel (300 meshes), which was purchased from QingDao Haiyang

Chemical Co., Ltd. P. R. China, was used for column chromatography.
The in vitro DPPH free radical scavenging assay and the alpha-amylase enzymatic
assay were measured by the Thermo Scientific Genesys 20 visible spectrophotometer.
2.4 Chemical Syntheses and Structural Characterization

2.4.1 Chemical Syntheses
A sample of gossypol acetic acid (500 mg, 0.97 mmol), potassium carbonate (1 g,
7 mmol) and dimethyl sulfate (1.5 g, 12 mmol) in acetone (10 mL) was refluxed for
48 hours according to the Adams’ method with minor modification (Figure 2.3)
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Figure 2.3 Methylation of gossypol with dimethyl sulfate

(Morris et al. 1937). Then acetone was removed under vacuum. The residue was
reconstituted into a solution by adding 15 mL of water before it was heated for 0.5 h
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to thoroughly hydrolyze the excess dimethyl sulfate. After the mixture was cooled
down to room temperature, ethyl ether (50 mL × 3) was added to extract the
gossypol’s methylated products that were separated and purified by preparative TLC
eluted with chloroform and methanol (150:1, v/v) to afford compounds 2, 3 and 4,
with 5.5%, 10.3%, 62.1% yield, respectively.
To obtain the compound 2 in a higher yield, the Haar’s method (Haar et al., 1952) was
applied with a minor modification. A solution of 500 mg of gossypol acetic acid (0.97
mmol), 10 ml of anhydrous acetone, 1 g of potassium carbonate (7 mmol, excess) and
1.4 g of methyl iodide (9.7 mmol) were mixed and refluxed gently for 48 hrs (Figure
2.4). Then the volatile solvent was removed by rotary evaporation. The residue was
purified with flash chromatography (silica gel, 300 – 400 meshes, CHCl3/MeOH =
150/1, vol) to give compounds 2, 3 and 4 with yield of 43%, 9.1%, 7.4%,
respectively.
2.4.2 Spectral data of gossypol derivatives
(The carbon position numbering of gossypol refers to Figure 2.2)
Gossypol hexamethyl ether in dialdehyde form (GHE, compound 2)
1

H-NMR (300 M Hz, in CDCl3) δ (ppm): 10.65 (2H, s, two protons of –CHO) 7.90

(2H, s, two sp2 protons of naphthol ring), 3.98 (6H, s, protons of two methoxyl group
at position 7 and 7′ ), 3.94 (6H, s, protons of two methoxyl group at position 6 and 6′),
3.96 (2H, m, protons attached to tertiary carbon in two isopropyl groups), 3.25 (6H, s,
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Figure 2.4 Methylation of gossypol with methyl iodine

protons of two methoxyl group at position 1 and 1′), 2.22 (6H, s, protons of methyl
group at position 3 and 3′), 1.57 (12H, m, protons of four methyl groups in the
isopropyl groups);

13

C NMR (125 MHz, in CDCl3 ) δ (ppm): 21.10, 22.18, 59.62,

61.10, 62.19, 122.81, 126.06, 127.85, 131.01, 135.29, 137.72, 149.60, 152.98, 193.19;
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UV-Vis: λmax/nm: 255, 294, 420; HRESI-MS m/z: 603.2816 [M+H]+, (Calcd for
C36H42O8, 602.2880); HPLC: TR=18.55 min;
Gossypol hexamethyl ether in monoaldehyde-monolactol form (GHE′, compound
3)
1

H-NMR (300 M Hz, in CDCl3) δ (ppm): 10.60 (1H, s, the proton of –CHO) 7.91

(1H, s, the sp2 proton of naphthol ring at position 4), 7.50 (1H, s, the sp 2 proton of
naphthol ring at position 4′ ), 7.20 (1H, s, the proton at position 9′), 4.21(3H, s,
protons of methoxyl group attached to 9′ carbon), 3.96 (6H, s, protons of two
methoxyl group at 7 and 7′), 3.91(6H, s, protons of two methoxyl group at 6 and 6′),
3.05 (3H, d, protons of two methoxyl group at 1), 2.24 (6H, s, protons of methyl
group in 3 and 3′), 1.56 (12H, m, protons of four methoxyl group in isopropyl groups);
13

C NMR (125 M Hz, in CDCl3 ) δ:20.96, 21.00, 22.08, 27.17, 29.71, 58.39, 58.43,

60.43, 60.47, 62.18, 103.04, 112.11, 115.59, 117.98, 122.55, 127.48, 130.89, 136.00,
136.29, 137.38, 137.75, 147.73, 149.37, 150.09, 153.92, 192.91; HRESI-MS m/z:
603.2948 [M+H]+, (Calcd for C36H42O8, 602.2880);
Gossypol tetramethyl ethers (compound 4)
1

H-NMR (300 M Hz, in CDCl3) δ (ppm): 10.60, 7.93, 7.92, 7.50, 7.09 , 6.98, 6.95,

4.16, 4.14, 3.98, 3.91, 3.54, 3.28, 2.35, 2.23, 1.58; Retention time for 4a-d in LC-MS
were 17.056, 18.825, 14.631, 13.635min (see Figure 2.5) with area percentage of
39.31%, 35.38%, 19.64% and 5.67%, respectively. HRESI-MS of 4a-d showed m/z:
573.2595 [M+H]+, (Calcd for C34H38O8, 574.2880);
2.5 DPPH antioxidant assay
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The DPPH free radical scavenging activity was determined by the modified
method (Yamaguchi et al., 1998). Solution of each sample (i.e., G stands for gossypol
acetic acid 1, GHE for gossypol hexamethyl ether in dialdehyde form 2, GHE′ for
gossypol hexamethyl ether in monoaldehyde and monolactol form 3, GTE for
gossypol tetramethyl ether 4, and BHT for butylated hydroxytoluene) dissolved in
dichloromethane were prepared for 0 - 200 ppm. An aliquot of 0.5 mL of the solution
was mixed with 0.4 mL of 0.25 mM solution of DPPH in dichloromethane. The
solution was sealed and shaken vigorously and then incubated in the dark at room
temperature for 15 min. Absorbance at 517 nm was measured. The DPPH antioxidant
activity was calculated as scavenging activity (%) = (1-absorbanceof sample at 517
nm/ absorbance of control at 517 nm) ×100% (Dowd et al., 2006).
2.6 Alpha-amylase inhibition assay
The DNSA regent (Wang et al., 2008) was prepared as a mixture of 1 g of 3,
5-dinitrosalicylic acid, 20 mL of NaOH (2 M), 50 mL of H2O and 30 g of potassium
sodium tartrate. After ultra sonication, certain amount of water was added to make the
mixture in total volume to 100 mL.
The alpha-amylase inhibitory activity was determined using the type VI-B porcine
pancreatic alpha-amylase. An aliquot of DMSO (100 µL, containing sample with
certain concentration) was added into starch solution (500 µL, 1%). The mixture were
incubated at 45 oC for 10 min immediately after adding alpha-amylase solution (400
µL, 50 µg mL-1 in 0.02 mol L-1 sodium phosphate buffer, pH=6.9 with 6 mmol L-1
NaCl), incubation was timed accurately. After incubation, the reaction was terminated
by adding 2 mL of DNSA regent. Then, the test tubes were incubated at 90oC in water
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bath for 10 min accurately. At the end of this period, the test tubes were cooled down
in tap water and diluted by addition of 22 mL of distilled water. Absorbance was
measured at 540 nm by the Genesys 20 visible spectrophotometer. Each absorbance
subtracted the absorbance measured under the exact same condition without the
amylase (same volume, same temperature, same time intervals, same ratio of starch
solution, etc.). The control absorbance was measured for that of the mixture without
sample at the same condition. In addition, the control should also subtract the
absorbance without the amylase and sample.
Standard curve was prepared by maltose. In brief, 1 mg mL-1 of stock solution of
maltose was diluted into final concentrations of 8-80 µg mL-1. Each test tube was
added by 2 mL of DNSA regent and 2 mL of maltose solution (final concentration is
8-80 µg mL-1). After incubation at 90oC in water bath for 10 min, the mixtures were
cooled down in tap water and diluted with 21 mL of distilled water. The absorbance
was measured at 540 nm. The enzymatic regression equation was determined as Y=
0.0044X-0.0367 and R² = 0.9985, where Y stands for the absorbance at 540 nm, and
X stands for maltose concentration (µg mL-1). Alpha-amylase activity was reflected
by resultant reducing sugar content during the reaction within certain time interval.
2.7 Anticancer assay
The MCF-7 cancer cells were cultured in RPMI with 10% fetal bovine serum
respectively. The cell line was incubated at 5% CO2 and 90-100% relative humidity at
37°C. Medium renewal was carried out 2-3 times per week, and cells were
subcultured when they achieved 80-90% confluence. Prior to chemical treatment, 10 4
cells well-1 were seeded into a 96-well tissue culture plate and were allowed to attach
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for 24 h. The cells were then treated with a defined concentration of the test
compound dissolved in DMSO, which was limited to a 1% concentration in each well.
As negative controls, cells were treated with DMSO only. After a 24-hour’s
incubation, cell proliferation was determined with the CellTiter 96 aqueous
nonradioactivity cell proliferation assay (Promega, Madison, WI). Results were
recorded on a universal EL800 Bio-Tek microplate reader at 490 nm.
2.8 Results and discussion
Gossypol methylated ethers were prepared by using iodomethane and dimethyl
sulfate to produce selective gossypol ether tautomers in desired yields. In case of
mono-lactol and mono–aldehyde forms such as compounds 2 and 4b, the chemical
shift of the proton in lactol ring moved from 10.6 ppm to 7.09 ppm, and the tertiary
protons in benzene ring (position 4 and 4′) displayed two unequivalent signals around
7.5 and 7.9 ppm. In addition, the protons of methoxyl groups in position 1 and 1′
showed up around 3.4 ppm if they were in the aldehyde form, while the protons of
methoxyl groups in position 9 and 9′ had a downfield movement to around 4.1 ppm in
the lactol form. Moreover, the chemical shifts of the protons in the methyl groups at 6
and 6′, and 7 and 7′ pairs were found to have an upfield movement (or the nucleus

41

mAU Signal Intensity measured at 254 nm
17.056
700

571.2595

100

4a

18.825

600
4b

572.2772

%

500

14.631
573.2828

400
0
530

300

4c
535 540 545 550

555 560 565

570 575 580

200

13.635

100

4d

0
0

2.5

5

7.5

10

12.5

15

17.5

20

22.5 min

Figure 2.5 The LC/MS chromatogram of compounds 4a-d

were more shielded) from 3.94 ppm and 3.98 ppm in the dialdehyde form (compound
2) to 3.91ppm and 3.96 ppm in the monoaldehyde and monolactol form (compound 3),
respectively. The retention time of compounds 4a-d (Figure 2.5) was 17.056, 18.825,
14.631, 13.635 min respectively in the LC/MS chromatogram. The concentration ratio
of 4a:4b:4c:4d is 39.31: 35.38: 19.64: 5.67, which are exactly consistent with the
integration ratio of protons in the aldehyde groups and lactol groups from 1H NMR
spectra.
The DPPH free radical scavenging activity was used to evaluate the antioxidant
activities of gossypol and its ethers in different degree of methylation. Antioxidant
properties, especially radical scavenging activities, are very important due to the
deleterious role of free radicals in biological systems. Our results provide interesting
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insights into the antioxidants of gossypol and its derivatives, and shed more light onto
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Figure 2.6 The DPPH free radical scavenging activities of G, 6-MG,
6, 6'-DMG, GTE, GHE, GHE′ and BHT. (The numbering refers to
Figure 2.2)

their mechanisms as free radical scavengers. As shown in Figure 2.6, gossypol
possesses a significantly high antioxidant activity with its DPPH free radical
scavenging capacity over 80% within the concentration range of 20-200 ppm, of
which the IC50 value for gossypol was 9.2 ppm. Our previous research demonstrated
that the IC50 values for the 6-methoxygossypol (compound 5), and 6,
6′-dimethoxy-gossypol (compound 6) to scavenge the DPPH free radicals in the same
experimental system were 16.4 and 16.8 ppm, respectively, which were relatively
higher than that of gossypol. In this study, it was further confirmed that more
methylation of gossypol resulted in remarkably lower DPPH free radical scavenging
activities below 20% within the concentration range of 0-200 ppm, although the
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gossypol ethers still remained parts of antioxidant activity comparable to that of BHT.
Based on our experiments and study on this structure-activity relationship, it seems
the overall tendency of the functional modification of gossypol follows the rule of that
more hydroxyl group in gossypol is replaced by methyl group, the lower free radical
scavenging activity of the derivatives will have.
Besides, three possible antioxidant mechanisms of gossypol are shown in the
Figure 2.7.

Figure 2.7 Three possible antioxidant mechanisms of gossypol

44

Antioxidant polyphenols have been recognized that they are able to neutralize
radicals by three pathways, e.g., donating hydrogen atom through one-step H-atom
transfer (HAT), stepwise electron transfer proton transfer (ETPT) and sequential
proton loss electron transfer (SPLET) ) (Zhang et al., 2006). These antioxidant
pathways also fit for the antioxidant gossypol and some of its derivatives. Yet, the
antioxidant capacity of gossypol derivatives also depends on their modified molecular
structures.
It is clear from this investigation that the numbers and positions of hydroxyl groups
and other functional groups are important for the antioxidant and free radical
scavenging activities of gossypol and its derivatives. After the hydroxyl groups in
gossypol were partially and/or completely methylated, the H-atom donating capability
significantly decreased although partial free radical scavenging activity of the
methylated gossypol derivatives was preserved. This demonstrated that the conjugated
binaphthalene ring of the backbone of gossypol could also stabilize some free radicals
through the ETPT mechanism, although other aforementioned pathways might
coordinate and play the critical role for the free radical scavenging activity.
The alpha-amylase inhibitory activities of gossypol as well as their di/tetra/hex
methyl ethers were also examined (Figure 2.8). It was found that gossypol
hexamethyl ether (GHE), gossypol tetramethyl ether (GTE), 6-methoxygossypol
(6-MG), and 6, 6′-dimethoxygossypol (6, 6′-DMG) all displayed enzymatic inhibitory
ability at lower levels compared to acarbose, which is a well-known inhibitor of
α-glucosidases, α-amylases, cyclomaltodextrin glucanyltransferase (CGTase) and
dextransucrase and used as an anti-diabetic drug (Morris et al., 1937). However, in
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our surprise, it was found that gossypol activated rather than inhibited the enzyme. It
is postulated that the alpha-amylase have several tertiary structural forms in solution
that are in dynamic equilibrium with each other. The additives that give maximum

Figure 2.8 Alpha-amylase activity treating with G, GTE, GHE,
6-MG, 6, 6'-DMG and Acarbose at 8mM concentration

activation bind to the protein-enzymes to give a single, optimum structure that is fixed
and gives the maximum activity with activation. Our study attempts to give a hint for
further understanding of the fundamental issues behind the enzyme activation and
inhibition.
Furthermore, gossypol exhibited dose-dependent growth inhibition against the
breast cancer cell line MCF-7. Although the low-leveled methylated gossypol ethers
such as 6- methoxygossypol and 6, 6′- dimethoxygossypol have been demonstrated to
possess higher anticancer activity than gossypol to some extent (Wang et al., 2008),
the highly methylated gossypol ethers like compounds 2-4 (e.g., GTE, GHE, and
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GHE′) exhibited a remarkably weak or no anticancer activity against each cell line in
our experiment (Figure 2.9). We postulated that partial methylation of gossypol could
increase the lipophilic affinity of 6-MG and 6, 6′-DMG with cancer cells resulting in
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Figure 2.9 Growth inhibition of breast cancer MCF-7 incubated with G, GTE,
GHE and GHE′. Error bars represent standard deviations of three experiments.

higher toxicity against those cells, but higher methylation of hydrpoxyl groups could,
on the contrary, decrease and/or deprive the gossypol’s original strong activity that
relied on the hydroxyl and aldehydic groups. This unexpected finding needs further
investigation regarding the functionalities of the aldehyde and hydroxyl groups on
gossypol.
2.9 Conclusion
In this experiment, the tetra/hexmethyl ethers of gossypol were synthesized by
two modified methods using iodomethane and dimethyl sulfate. The gossypol ether
was successfully separated and fully characterized by NMR, MS, and HPLC. Four
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gossypol tetramethyl ether tautomers were also determined by LC/MS. In addition,
their free radical scavenging activity and inhibitory alpha-amylase activities were
measured. Gossypol possesses a high antioxidant activity, and also is a good
alpha-amylase activator, while gossypol hexamethyl ether (GHE), gossypol
tetramethyl ether (GTE), methoxygossypol (6-MG), and 6, 6′-dimethoxygossypol (6,
6′-DMG) all exhibited their inhibitory tcapability against the alpha-amylase. In
addition, gossypol ethers showed very weak or no anticancer activities, which were
correlated with the methylation level. Nevertheless, our results demonstrated that
gossypol and its derivatives possess many biological activities, and have potential to
be developed as drugs for some chronic diseases.
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Appendix I

Figure A2.1 The 1HNMR spectra of 2 (300MHz, CDCl3)
52

Figure A2.2 The 13CNMR spectra of 2 (300MHz, CDCl3)
53

Figure A2.3 The chromatogram HPLC of 2
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Figure A2.4 The 1HNMR spectra of 3 (300MHz, CDCl3)
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Figure A2.5 The 13CNMR spectra of 3 (300MHz, CDCl3)
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Figure A2.6 The 1HNMR spectra of 4 (300MHz, CDCl3)
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Figure A2.7 The ESI-MS spectra of 3, 2, 4 (form the top to the end respectively)
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(Figure A2.8-1)
59

(Figure A2.8-2)
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(Figure A2.8-3)
61

(Figure A2.8-4)
62

(Figure A2.8-5)
Figure A2.8 The LC-MS spectra of 4 (the MS spectra parts are for 19.0, 17.1, 14.5,
13.7min form the top the end respectively)
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CHAPTER 3

NOVEL-O-GLYCOSIDIC GOSSYPOL ISOMERS AND THEIR
BIOACTIVITIES

3.1 Abstract

Novel glycosidic gossypol analogues, gossypol diglycosidic tetraacetate 7,
gossypol diglycosidic tetraacetate 8, gossypol mono-glycosidic tetraacetate 9
gossypol diglycoside 10 and gossypol diglycoside 11 were obtained by the
ultrasound-assisted

reaction

of

potassium

salt

of

gossypol

with

3,

4,

6-tetra-O-acetyl-α-D-glucopyranosyl bromide under phase transfer catalytic (PTC)
condition. The new glycosidic gossypol derivatives were fully characterized by 1D
NMR (1H NMR,

13

C NMR, DEPT, 1D NOE), 2D NMR (HMBC, HMQC)

spectroscopy, HRMS/MS spectrometry, UV spectrometry as well as HPLC-PDA
technique. The biological activities of the novel glycosidic gossypol analogues were
explored in detail. The anticancer, antitrypanosomal activities as well as cytotoxicity
evaluation of those novel glycosidic gossypol derivatives exhibited that gossypol
diglycosidic tetraacetate 8 could be developed into a potential pharmaceutical
candidate in the treatment of cancer since it elicited powerful inhibition against cancer
cells (MCF–7 Human breast and HT-29 Human colon carcinoma cells) with
significantly low cytotoxicity compared with unfunctional gossypol. In addition,
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gossypol diglycosidic tetraacetate 7 and 8 possess antitrypanosomal activity with
LD50 value of 2.12 and 2.44 µM, respectively.

3.2 Background
A glycoside is any molecule in which a sugar group is bonded through its
anomeric carbon to another group via a glycosidic bond.

Figure 3.1 Structure of some phenolic glycosides existing in natural plants
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Glycosides can be linked by an O-(an O-glycoside), C-(a C-glycoside), N-(a
glycosylamine) or S-(a thioglycoside) glycosidic bond. The sugar group is then
known as the glycone and the non-sugar group as the aglycone or genin part of the
glycoside. In addition, the glycone can consist of a single sugar group
(monosaccharide) or several sugar groups. Common types of glycosides include
saponins, cardiac glycosides (cardenolides), cyanogenic glycosides, anthraquinone
glycosides and glucosinolates, many of which possess various biological functions,
e.g, as deterrents to herbivores (Majak, 1992; Duffey, S. S. 1980). Some examples of
natural phenolic glycosides are given in Figure 3.1.
Carbohydrates carrying aromatic aglycones are important natural products with
versatile bioactivities and thus key synthetic targets. The most common carbohydrate
donors used for aromatic O-glycosylation are anomeric acetates, halides,
trichloroacetimidates and thioglycosides as well as some other less common donors.
Anomeric acetates or trichloroacetimidates, which are activated under acidic
conditions, are preferred for electron rich aromatic aglycons; while glycosyl halides,
which are activated using basic conditions, are preferred for electron deficient
aromatic residues (Jacobsson et al., 2006).
Before the introduction of gossypol glycosylation, it is worth to mention an
important reaction: the Koenigs–Knorr reaction (Figure 3.2) which was reported in
1901 and thus, it is one of the oldest, simplest but most useful reactions for
preparation of a wide variety of O-glycosides. It is useful for coupling reactions with
either alkyl or aromatic alcohols as well as for coupling between sugars. The
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methodology requires silver salts as catalysts. Among them, the oxide, carbonate,
nitrate, triflate silver salts are the most commonly employed. Also a drying agent such
as calcium sulfate, calcium chloride or molecular sieves is recommended (Fischer et
al., 1901; Koenigs et al., 1901).

OAc
A cO
A cO

O
H

H

O

X = B r, C l

+ ROH

X

AC
A lco h ol

G ly co syl h alid e
p rom o te r
OAc
AcO
A cO

H

O
OR
OAc

H

G lyco sid e

Promoters

Conditions

Ag2CO3

PhH, drierite (drying agent), I2

Ag2O

S-collidin (acid scavenger)

AgNO3

HgO (acid scavenger)

AgClO4

AgClO3 (acid scavenger),THF or toluene, r.t.

AgOTf

CH2Cl2, r.t.
Figure 3.2 The Koenigs–Knorr reaction
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3.3 Introduction
The naturally occurring sesquiterpene dimer gossypol and its derivatives have
long been a subject of interest to medicinal chemists due to their great potentials in
pharmaceutical and industrial applications. This polyphenolic pigment displays
various promising biological properties including contraceptive (Porat, 1990),
anticancer (Moon et al., 2008; Shelley et al., 2000), antiviral (Radloff et al., 1986),
and antifungal properties (Przybylski et al., 2009b). However, the relatively high
toxicity of gossypol (Clark, 1927; Gallup et al., 1931) precludes its application in
medical therapy, for this reason the syntheses and tests of potentially less toxic
gossypol analogues are desired to enable their application as drugs. Many gossypol
derivatives including its Schiff bases (Przybylski et al., 2009a), gossypol ethers
(Adams et al., 1938; Morris et al., 1937), apogossypol series derivatives (Meltzer et
al., 1985), gossypolone (Haas, 1965), gossindane (Talipov et al., 1999), halogenated
gosspol (Zhu et al., 1992), periacetylated gossylic nitriles, periacetylated gossylic
imino-lactones, azo-derivatives, hydrazones, thioderivatives of gossypol have been
obtained and tested for their antipsoriatic, antimalarial, antitumor, interferon-inducing
as well as anti-HIV activities (Przybylski et al., 2009c; Dodou et al., 2005;
Razakantoanina et al., 2000; Rezhepov et al., 2002; Liang et al., 1995; Royer et al.,
1995).
However, among those gossypol derivatives, no studies about gossypol
glycosides have been reported up to now. As mentioned above in Section 3.2
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background, glycosides are a main type of sources of natural medicines, cosmetics,
and some functional food ingredients, which possess essential biological functions
that make them the key synthetic targets. On one hand, gossypol glycosylation
products may have increased solubility and thus make them more easily absorbed by
the intestine; on the other hand, gossypol glycosides may undergo different
metabolism pathways with reduced toxicity. However, regardless of these potential
advantages, phenols such as gossypol are difficult to be glycosylated due to the
electron-withdrawing properties of aromatic rings (Jacobsson et al., 2006).
In this paper, novel glycosidic gossypol isomers were synthesized through
ultrasound assisted reaction of 2, 3, 4, 6-tetra-O-acetyl-α-D-glucopyranosyl bromide
with potassium salt of gossypol under PTC conditions and were fully characterized by
1D NMR (1H NMR, 13C NMR, DEPT, 1D NOE), 2D NMR (HMBC, HMQC), HRMS,
HPLC. Besides, we explored the antioxidant capacity, antitumor effects and the
cytotoxicity of the glycosidic gossypol isomers and their hydrolyzed products.

3.4 Experimental
3.4.1 Material
2, 2′-Bi [8-formyl-1, 6, 7-trihydroxy-5-isopropyl-3-methylnaphthalene]) acetic
acid (gossypol acetic acid, MW=578.6, C30H30O8•C2H4O2, HPLC purity >95%) was
purchased

from Zhejiang Yixin Pharmaceutical Co.,

Tetrabutylammonium

bromide,

99+%

(MW=322.36

69

Ltd.

P. R.

C16H36BrN),

2,

China.
3,

4,

6-tetra-O-acetyl-alpha-D-galactopyranosyl bromide (MW=411.21, C14H19BrO9), were
products form Acros organics, New Jersey, USA. Dimethyl sulfoxide (DMSO),
potassium carbonate (K2CO3), and phosphoric acid (H3PO4) were purchased from
Sigma Chemical Co., (St. Louis, MO). Amerlite ion exchange resin (IR-120 H. C. P.)
has medium porosity and moisture holding capacity of 44-48%, which is composed of
strong acidic, sulfonated polystyrene type cation exchange resin (RSO3-H+). All
solvents for chromatographic isolation were of analytical grade. HPLC grade
methanol, dichloromethane, acetone, and chloroform were purchased from Fisher
Scientific Company (Fair lawn, N.J. USA).

Tissue culture plates were purchased

from Costar Corp. (Cambridge, MA). Heat-inactivated fetal bovine serum, fetal
bovine serum, and newborn calf serum were purchased from Hyclone Laboratories,
Inc. (Logan, UT).

MCF-7 (human breast cancer), HT-29 (colon cancer) cancer cell

lines and 3T3L1 preadipocytic cell line were purchased from the American Type
Culture Collection (ATCC) (Rockville, MD). MCF-7 cells were cultured in
RPMI-1640 with 10% newborn calf serum and HT-29 cells were cultured in RPMI
with 10% fetal bovine serum instead of the newborn calf serum. The base medium for
3T3L1 preadipocytic cells is ATCC-formulated Dulbecco's Modified Eagle's
Medium, Catalog No. 30-2002. To make the complete growth medium, the following
components were added to the base medium: bovine calf serum to a final
concentration of 10%. All cell lines were incubated at 5% CO2 and 90-100% relative
humidity at 37°C. Medium renewal was carried out 2-3 times per week, and cells
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were

subcultured

when

1-diphenyl-2-picrylhydrazy

they

achieved

(DPPH),

butylated

80-90%

confluence.

hydroxytoluene

(BHT),

1,
3,

5-dinitrosalicylic acid (98%)(DNSA), alpha-amylase (Type VI-B, from porcine
pancreas), starch from potatoes ((C6H10O5) n, Mr=162.14n) was purchased from Fluka,
Germany. Potassium sodium tartrate (KNaC4H4O6•4H2O, FW=282.231), sodium
hydroxide were purchased from J. T. Baker Chemical Co., (Phillipsburg, N.J. USA).
Sodium phosphate (Na2HPO4, FW=141.96), Sodium chloride were purchased from
Fisher Scientific Company (Fair lawn, N.J. USA).
3.4.2 Instruments for chemical analysis
HPLC analysis was carried out on a Shimadzu HPLC system that included
LC-20AT solvent delivery pumps, a CBM-20A communication bus module, a
SPD-M20A photo-diode array detector, and the ClassVP operating software.
The HPLC was equipped with a Kromasil RP C18 column (particle size of 5µm,
column size of 150 mm×4.6 mm, Alltech Associates, Inc. Deerfield, IL), which was
placed in a column oven (CTO-20A) under a constant temperature at 25 oC. The
mobile phase consisted of methanol: H2O = 87:13 (v/v) containing 0.1% aqueous
H3PO4. The column flow rate was set at 1 ml min-1, while the HPLC pressure was
controlled between 1020-1040 psi.
Mass spectrum were obtained by a nanoflow capillary HPLC coupled with a
quadrupole time-of-flight micro mass spectrometer (Q-TOF-MS) (Waters Corp.,
Milford, MS) with an electrospray ionization (ESI) in both ESI-MS and ESI-MS-MS
modes operated by the Masslynx software (V4.0, Waters Corp., Milford, MS). Each
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separated and purified sample was directly injected from the sample vial into the ESI
source in methanol at a flow rate of 1.5 µL min-1. The ion source voltages were set at
±3000V for positive and negative ion mode acquisitions, respectively. In both modes,
the source temperature was maintained at 100°C and the mass spectrum was scanned
from 100 to 800 m/z at 1 second with 0.1-second inter-scan delay in continuum mode.
For

MS/MS

analysis,

mass

spectrum

was

scanned

from

50-800

m/z.

Glu-fibrinopeptide (Sigma) as a mass standard in ESI-MS and ESI-MS/MS mode was
infused through the nanoLockspray (Waters Corp., Milford, MS) for single point, real
time, and accurate mass calibration. Raw spectra were processed using the MassLynx
software (V4.0). Precursor ion scans on positive and negative ion modes using low
energy collision induced dissociation (CID) resulted in more structural fragments,
which helped structural identification of compounds of interest.
LC/MS analysis was performed on an Agilent 6100 series LC/MS in which a
quadrupole mass spectrometer was coupled to an Agilent 1200 HPLC that consisted
of a G1329A high performance autosampler (hp-ALS-SL), a G1312A binary pump
(BIN-SL), a G1379B vacuum degasser, a G1316A thermostatted column
compartment (TCC-SL) and a G1314B variable wavelength detector (VWD-SL).
The quadrupole mass spectrometer was operated with an atmospheric pressure
electrospray ionization (API-ES) source in positive mode. The flow rate of HPLC was
maintained at 1 mL/min through a Kromasil RP C18 column (particle size of 5 µm,
column size of 150 mm×4.6 mm, Alltech Associates, Inc. Deerfield, IL). The mobile
phase in an isocratic elution consisted of methanol and water (v/v=87:13) containing
0.1% formic acid. Mass spectra were recorded within the m/z range of 100-1000. The
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dry gas flow for MS was 13.0 L/min, the nebulizer pressure was 30 psig, dry gas
temperature was 350 0C, and the Vcap voltage was 3500 V. Data was acquired from
and processed by the Agilent LC/MSD ChemStation software.
The instrument used for infrared (IR) spectral analysis was a PerkinElmer 1725
series FTIR spectrometer (PerkinElmer Corporation, Norwalk, CT) equipped with a
room temperature deuterated triglycine sulfate detector and controlled by a
PerkinElmer 7300 PC.

The software used for collecting the FTIR data was the Spectrum version 5.3.1.
The instrument was purged with dry nitrogen and maintained with two automatic
dehumidifiers to minimize CO2 and water vapor interference. Melted drops of each
standard were placed in a transmission cell with sodium chloride (NaCl) windows.
The transmission path of 25 µm was adjusted using a polytetrafluoroethylene spacer.
The cell was then placed in the cell holder in the FTIR spectrometer before the sample
was scanned. The transmission cell was rinsed three times with acetone and then dried
with a soft tissue before the next sample was put in. Calibration spectra were collected
by 81 scans of each of the 45 standards at a resolution of 4 cm−1, gain of 1.0, and
strong apodization throughout the mid-IR region of 4000–400 cm−1.All the spectra
were subtracted from the background KBr spectrum. All the samples were scanned in
duplicate.
The UV-Vis absorbance spectra are recorded by the SPD-M20A photo-diode
array spectrophotometer.
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1D and 2D NMR (1H NMR,

13

C NMR, DEPT, HMQC, HMBC) spectra were

acquired from a Bruker AV-500 spectrometer or JEOL operated at 300 MHz for 1H
NMR and 75 MHz for

13

C NMR. Data were processed by the Bruker XWINNMR

3.50 programs.
In addition, thin layer chromatography (TLC) analytic plates were F254 plates
precoated with silica gel 60Å and fluorescent reagent (Merck, Darmstadt, Germany &
Whatman, New Jersey, USA). The TLC preparative plates are Partisil PK6F,
precoated with silica gel 60Å, 20×20cm, layer thickness is 250 or 1000 µm.,
purchased from Whatman Inc, New Jersey, USA. The TLC was visualized at 254 nm
in a UV-viewing system purchased from Fisher Biotech. Silica gel (300 meshes),
which was purchased from QingDao Haiyang Chemical Co., Ltd. P. R. China, was
used for column chromatography.
3.4.3 Chemical syntheses and structural characterization
The synthetic procedure for the glycosidic gossypol isomers is depicted in Figure
3.3. To a mixture of gossypol acetate (500 mg, 0.864 mmol, 1eq) in
dichloromethane/acetone (v/v=5:1, 25 ml) and 2, 3, 4, 6- tetra-O-acetyl-α
-D-glucopyranosyl bromide (711mg, 1.728 mmol, 2eq) in dichloromethane (5 ml),
aqueous KOH (0.3 g, 5mmol in 10 ml water) and

tetrabutylammonium

bromide

(0.6 g, 1.86 mmol in 10 ml water) were added. The mixture was ultrasonicated until
the completion of the reaction (at least 6 hrs at room temperature), which was
indicated by phase separation and analyzed by TLC (dichloromethane/methanol
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Figure 3.3 The glycosylation of gossypol
(7 or GS1:7, 7'-gosspol di-glucosidic tetraacetate
8 or GS2:6, 7'-gosspol di-glucosidic tetraacetate)
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=20:1). The organic layer was washed with water, dried over anhydrous sodium
sulfate and distilled under reduced pressure. The crude sample was loaded onto a
silica gel (300 mesh) column and eluted out with gradient from 100% petroleum ether
to the mixture of petroleum ether-acetone in 10/1 to the final concentration ratio 3/1
(V/V). The isomers were finally elaborately separated by preparative TLC
(dichloromethane/ methanol=20:1), pure fractions were pooled and evaporated to
afford 7, 7′-gosspol di-glucosidic tetraacetate 7 in 36% yield (0.36g) and 6, 7′-gosspol
di-glucosidic tetraacetate 8 in 24% yield (0.24g) and trace amount of gossypol

Figure 3.4 Hydrolysis of compounds 7 and 8
(10 or GS1':7, 7'-gosspol di-glucoside
11 or GS2':6, 7'-gosspol di-glucoside)
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mono-glucosidic tetraacetate 9. The gossypol glucosidic tetraacetates could be
converted into gossypol glucosides quantitatively in dry methanol (10 mL) and
sodium methoxide. The deacetylation reaction (Figure 3.4) was monitored via TLC.
At the end of the reaction (30 min), the solution was neutralized by the addition of
freshly regenerated IR-120 H+ resin.
All structures of glycosylated gossypol derivatives were fully characterized via
rigorous structure determination through multiple spectral experiments such as 1D
NMR (1H NMR,

13

C NMR, DEPT and 1D NOE), 2D NMR (HMBC, HMQC), UV

spectroscopy, HRMS as well as HPLC technique.
3.4.4 Experimental results and discussion
The negative-ion mode HR-nano-ESI Q-TOF MS/MS spectrum of 7 showed the
molecular ion peak of C58H66O26 at m/z 1177.4166 (intensity 100%) and two other
major peaks at m/z 847.2607 (intensity 35%) and 516.1364 (intensity 20%)
corresponding to the fragments from 7 which lost one and two glycosyl groups
respectively (see Figure 3.5). The fragment structure in blue bracket is corresponding
to the mass peak from which the arrow in blue pointed, the same to the red ones).
Similar MS/MS spectra of 8 showed the molecular ion peak of C58H66O26 at m/z
1177.4055 and two fragment peaks at m/z 847.2491 and 516.1309 as shown in Figure
3.6. The compound 9 showed the molecular ion peak of C44H48O17 at m/z 847.2687
corresponding to the gossypol mono-glucosidic tetraacetate (Figure 3.7).
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1

H NMR (300 MHz, CDCl3) data of 7: 1.52 (d, 12H, J=3Hz, -CH3 at 12, 12', 13

and 13'), 2.21 (m, 12H, -CH3 of -OAc groups), 2.31 (s, 6H, -CH3 at 15 and 15'), 3.81
(m, 2H, J=3Hz, -CH= at 11 and 11'), 4.26 (m, 4H, -CH=, sp 2 protons in sugar
residues), 5.16-5.52 (m, 5H, -CH=, sp protons in sugar residues), 6.34(-OH), 7.06(d,
2H, J=2Hz, -CH=, sp protons at 14 and 14'), 7.42(s, 2H, sp protons at 4 and 4').
1

H NMR (300 MHz, CDCl3) data of 8: 1.52 (t, 12H, J=3Hz, -CH3 at 12, 12', 13

and 13'), 2.16 (m, 12H, -CH3 of -OAc groups), 2.28 (s, 6H, -CH3 at 15 and 15'), 3.79
(m, 2H, J=3Hz, -CH= at 11 and 11'), 4.15 (m, 4H, -CH=, sp 2 protons in sugar
residues), 4.25-5.52 (m, 5H, -CH=, sp protons in sugar residues), 5.18(-OH),

Figure 3.5 The ESI- Q-TOF MS/MS spectrum of 7
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6.36(-OH), 7.08(s, 2H, -CH=, sp protons at 14 and 14'), 7.39(s, 2H, sp protons at 4
and 4').
13

C NMR data of 7 (75MHz, CDCl3): 20.54, 20.61, 20.75, 20.96, 21.33, 26.97,

30.90, 61.65, 66.77, 69.47, 70.17, 70.80, 76.61, 77.03, 77.23, 77.45, 100.67, 102.87,
109.24, 114.15, 117.88, 120.17, 126.62, 127.60, 138.25, 138.59, 146.01, 155.12,
169.99, 170.20, 170.92, 171.52.

Figure 3.6 The ESI- Q-TOF MS/MS spectrum of 8
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Figure 3.7 ESI- Q-TOF MS spectrum of 9

13

C NMR data of 8 (75MHz, CDCl3): 20.53, 20.61, 21.04, 21.24, 21.33, 26.94,

30.92, 62.06, 67.03, 69.41, 70.07, 71.02, 76.60, 77.02, 77.22, 77.45, 99.90, 103.08,
109.29, 114.09, 117.70, 119.95, 126.35, 127.45, 137.96, 138.22, 145.93, 154.94,
170.00, 170.28, 170.65, 171.45.
The 1H NMR spectrum of 7 clearly showed one set of doublet proton resonance
(methyl groups at 12, 13 and 12′, 13′ position) at 1.52ppm (Figure 3.9) while the 1H
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Figure 3.8 The change of the signal at 6.3ppm in 1H NMR spectra of 7 after CD3OD
were added
NMR of 8 showed two sets of doublet proton resonance signals at 1.52ppm for the
methyl groups at the same position (triplet at 500MHz, doublet of doublets at
300MHz, J=3Hz). The signal at 6.3ppm in both 1H NMR spectra of 7 and 8 became
less intense after a few drops of CD3OD added into the sample tube (Figure 3.8)
indicating that one of the OH groups left in gossypol framework of gossypol. The
identification of hydroxyl group in gossypol framework (left: before adding CD3OD;
right: after adding CD3OD). glucosidic molecule gave rise to the signal at 6.3ppm for
both 7 and 8. The protons attached to carbon 14′ were demonstrated to be in a
hemiacetal form according to the appearance of the signal at 7.02ppm and absence of
aldehyde signal at 11ppm.
The

13

C NMR and DEPT spectra of 7 (in CDCl3) (See AddendixII, Figure
81

A3.1, A3.2, A3.14) located a set of CH2 peaks from glucoside moiety at 61.96ppm, a
set of CH peaks at 27.01ppm for methine group at position 11 and 11′, four sets of
tertiary carbon peaks from glucoside moiety at 66.99, 69.28, 70.01, 71.25 ppm
respectively, the other three sets of tertiary carbon peaks from the carbon in the
hemiactal structure of gossypol, the anomeric carbon of glucoside moiety and the
tertiary carbon of benzene at 100.66, 102.88, 114.15ppm respectively. The compound
8 possesses

13

C NMR and DEPT spectra similar to that of 7 but some of the signals

split and have more fine signals.

H OAc
HO

AcO
AcO

H OAc
H

PhH
OH
H C O

-OH

HOHC
O
H
HO

O

O

CHOH
O

H AcO
OH

C
H

spH in
sugar
residue

H
O

AcO
H2C Sugar

CH3

OAc

H
OAc
OAC

H

sp3H
of
-OAc

H3C

CH3

CH

Figure 3.9 The 1H NMR spectrum of 7 (in CDCl3, 300 MHz)
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In addition, the ultraviolet absorption spectra (Figure 3.10) of gossypol
diglucosidic tetraacetates and gosspol diglucosides all have profound hypsochromic
shift comparable to the unfunctional gossypol. Ultraviolet and visible light have
sufficient energy to cause only two electronic transitions, the promotion of a
nonbonding (lone-pair) electron (n) into an antibonding molecular orbital (n to π*
transition), the higher energy electronic transition is the promotion of an electron from
a bonding molecular orbital into an antibonding molecular orbital (π to π* transition).
While the ultraviolet absorption spectrum of pure gossypol shows three well separated
bands at 235, 288, 372 nm since it contains conjugated Pi-electron system, the
strongest absorbance is at 235nm, after glycosylation, the compound 7-11 presumably
due to the substitution of the two bulky glycosidic groups which could cause
distortion of the naphthalene ring in the gossypol framework, besides, the conversion
from the dialdehyde form to the dilactol form and substitution also affected the
electron density and the conjugation system. The UV spectra showed that
glycosylation of gossypol could alter the relative intensities of the main UV
absorption bands. There is hyperchromic shift at 266 nm except of the hypsochromic
shift for the absorption bands.
The UV-Vis of gossypol: max/nm (MeOH) 235(strongest), 288, 372; HPLC:
tR=7.94min; mobile phase: CH3OH: H2O=87:13 (0.1% H3PO4), the average
pressure=1052psi, flow rate=1ml/min;

83

The UV-Vis of 7, 7'-gosspol diglucosidic tetraacetate (Compound 7): max/nm
(MeOH) 206, 225, 260 (strongest); HPLC: tR=1.63min; mobile phase: pure CH3OH,
the average pressure=600psi, flow rate=1ml/min;
The UV-Vis of 6, 7'-gosspol diglucosidic tetraacetate (Compound 8): max/nm
(MeOH) 205, 225, 260 (strongest); HPLC: tR=1.84 min; mobile phase: pure CH3OH,
the average pressure=600psi, flow rate=1ml/min;
The UV-Vis of 7, 7'-gossypol diglucoside (Compound 10): max/nm (MeOH) 206,
226, 261 (strongest); HPLC: tR=1.49 min; mobile phase: pure CH3OH, the average
pressure=597psi, flow rate=1ml/min;
The UV-Vis of 6, 7'-gossypol diglucoside (Compound 11): max/nm (MeOH) 206,
227, 261 (strongest); HPLC: tR=1.59min; mobile phase: CH3OH: H2O=87:13 (0.1%
H3PO4), the average pressure=600psi, flow rate=1ml/min.
See Page 71 about the other additional HPLC conditions.
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Figure 3.10 The UV/vis absorbance spectra for gossypol, gosspol diglucosidic
tetraacetates, gosspol diglucosides
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Figure 3.11 The arrow indication of the NOE correlation in the structure of
compound 7, a-f refer the protons at different position in the molecule

All the data indicate that the two glucose molecules in compound 7 is
symmetrical, while it is unsymmetrical for compound 8. There are two possible
isomers of 1: 6, 6′ or 7, 7′-double substitution. In order to discriminate the possible
configuration, 1D NOE experiments were carried out (Figure 3.11 and 3.12). The
arrows in (A) indicate the mutual NOE correlations. The protons at position b and
a were irradiated separately, the proton signals which arise from a, c and d give
NOE in response to the irradiation of signal b, while the signals of b, e and f give a
NOE in response to the irradiation of signal a. The protons of the hydroxyl group
left in the gossypol framework and the methyl groups at position b are spatially
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2

(A)

(B)

Figure 3.12 1D NOE spectra of isomer 7 (500MHz),
(A) Irradiating proton signal at b position
(B) Irradiating proton signal at a position.
Position refers to Figure 3.11.
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close enough to elicit an NOE response which gives an evidence of

compound 7

to be 7,7′-substitution. Interestingly, the hydrolyzed products of 10 and 11 exist as
dialdehyde form according to the reappearance of proton signal at 11.1ppm in the
1

H NMR spectra. The new gosspol glucosidic tetraacetates are relatively stable in

air. While stocking in methanol, they would undergo hydrolysis slowly possibly
due to larger proton activity and less 3D hydrogen bonded structure as well as
higher solubility of gossypol glucosidic tetraacetates in methanol than the other
solvents.
Let me disscuse the FT-IR spectra of gossypol and glycosylated gossypols
(Figure 3.13-15). The starting material, gossypol acetic acid is a complex which
consists of one gossypol molecule and one acetic acid molecule through hydrogen
bonding, there are no additional hydro-gen bonds between these complexes,
gossypol crystal structure is stabilized by Van der Waals interactions only. The
functional group region of 4000-1400 cm -1 an IR spectrum is where most of the
functional groups show absorption bands; the finger print region of 1400-600 cm-1
is characteristic of the compound as a whole. In the functional region of the FT-IR
spectrum of unmodified gossypol, two clear bands at 3503.37 and 3425.63 cm-1
assigned to different types of hydroxyl groups involved in the hydrogen bonds of
different strength are observed, in contrast, the rest O-H groups after gossypol
glycosylation show stretches at 3502.34 cm-1 for the compound 8 and 3481.20 cm-1
for the compound 7 which is the only difference at absorption frequency for these
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two isomers, and it also give a further evidence to indicate that the O-H groups
exist in different chemical environment further. Also, the FT-IR spectrum shows
the stretching vibration mode of C=O of the ester group in eight acetyl groups of
the gosspol diglucosidic tetraacetates show the strongest absorption band at the
frequency of 1754.79 cm -l for both Compound 7 and 8, while the FT-IR spectrum
of unglycosylated gossypol show absorption at 1712.01 cm -l with medium
intensity for the stretching vibration of C=O in the aldehyde groups. The frequency
occurs at around 2961.07 cm-l reflect sp 3 C-H scissoring vibration mode for both
glycosylated gossypol and pure gossypol. In addition, the increased C-O bonds of
both Compound 7 and 8 show strong stretches at 1223 cm -l in the fingerprint
region.
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Figure 3.13 The FT-IR spectrum of 7, 7'-gosspol diglucosidic tetraacetate
(Compound 7) in KBr pellet in the range 4000–370 cm-1
[IR ν/cm-1 (KBr) of 7, 7'-gosspol diglucosidic tetraacetate (Compound 7): 3481.20,
2961.13, 1754.79, 1634.30, 1440.89, 1370.27, 1223.64, 1159.13, 1072.79, 875.06,
601.75, 397.23, 376]
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Figure 3.14 The FT-IR spectrum of 6, 7'-gosspol diglucosidic tetraacetate
(Compound 8) in KBr pellet in the range 4000–370 cm-1
[IR ν/cm-1 (KBr) of 6, 7'-gosspol diglucosidic tetraacetate (Compound 8): 3503.37,
3425.63, 1961.07, 1712.01, 1577.13, 1613.81, 1441.09, 1381.10, 1339.22, 1297.84,
1179.01, 1123.59, 1053.13, 966.65, 912.80, 772.49, 611.99, 542.43, 478.40, 394.83,
385.83]
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Figure 3.15 The FT-IR spectrum of gosspol in KBr pellet in the range 4000–370 cm-1
[IR ν/cm-1 (KBr) of gossypol: 3503.37, 3425.63, 2961.07, 1712.01, 1613.81,
1577.13, 1441.09, 1381.10, 1339.22, 1297.84, 1179.01, 1123.59, 1053.13, 966.65,
912.80, 842.15, 772.49, 642.43, 611.99, 478.40, 394.83, 385.83]
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The anticancer activities of gossypol, 7, 7′-gosspol diglucosidic tetraacetate, 6,
7′-gosspol diglucosidic tetraacetate, 7, 7′-gosspol diglucoside and 6, 7′-gosspol
diglucoside were investigated by using an MTT (3-(4, 5-dimethyl- thiazole-2yl)-2,
5-diphenyl tetrazolium bromide) assay on human colon adenocarcinoma HT-29
and breast adenocarcinoma MCF-7 human cancer cell lines, the results are
presented in Figure 3.16. When the growing cancer cell cultures achieved 80-90%
confluence, they were incubated for another 24 hours right after chemical
treatment. The result was recorded on a universal EL800 Bio-Tek microplate
reader at 490nm. A mitochondrial enzyme in living cells, succinate dehydrogenase,
cleaves the tetrazolium ring and converts the MTT into an insoluble purple
formazan and the amount of formazan produced is directly proportional to the
number of viable cells. The cytotoxicity of gossypol, 7, 7′-gosspol diglucosidic
tetraacetate, 6, 7′-gosspol diglucosidic tetraacetate, 7, 7′-gosspol diglucoside and 6,
7′-gosspol diglucoside to 3T3L1 adipocytes evaluated with an LDH (lactate
dehydrogenase) assay were shown in Figure 3.17. The cells were incubated for 4
hours after chemical treatment, cell death in the cultures was assessed by
determining release of lactate dehydrogenase from the cells into the culture
medium. Results from two assays (MTT and LDH) to cancer cell lines and
adipocytes showed that the cytotoxicity of compound 7, 7′-gosspol diglucosidic
tetraacetate, 7, 7′-gosspol diglucoside and 6, 7′-gosspol diglucosidic tetraacetate,
were significantly lower than gossypol and 6, 7′-gosspol diglucoside at P<0.05.

93

Figure 3.16 Growth inhibition of human breast MCF-7 cancer cell line (top) and
human breast HT-29 colon cell line (bottom) incubated with gossypol, gossypol
diglycosidic tetraacetates (compound 7 and 8), gossypol diglycosides (compound 10
and 11) for 24 hrs. Error bars represent standard deviations of six experiments, and
different letters represent significant difference at P > 0.05. G stands for Gossypol,
GS1 for 7, GS2 for 8, GS1' for 10, GS2' for 11, see Figure 3.3 and 3.4 about the
numbering
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The relative cytotoxicity at concentration of 50µM are 57.99%, 22.11%,
23.27%, 23.22%, and 71.05% for gossypol, 7, 7′-gosspol diglucosidic tetraacetate,
6, 7′-gosspol diglucosidic tetraacetate, 7, 7′-gosspol diglucoside and 6, 7′-gosspol
diglucoside respectively, while the anti-proliferation activity for cancer cell lines
(eg. HT-29 colon cancer cell) at 50µM of those five glycosidic gossypols are
24.57%, 68.85%, 47.26%, 68.29% and 39.95% respectively which give hints that
the 6, 7′ isomer-gossypol diglycosidic tetraacetate (compound 8), targetedly
inhibits cancer cell growth with reduced cytotoxic effect to normal cells

Relative Cytotoxicity (100%)

comparable to un-functionalized gossypol.

120
100

G
GS1
GS2
GS1'
GS2'

80
60
40
20
0
0

100

200

300

Concentration (µM)
Figure 3.17 The cytotoxicity of gossypol and its glycosidic analogues, data is means
of three or more determinations, SD were within 5%. G stands for Gossypol, GS1 for
7, GS2 for 8, GS1' for 10, GS2' for 11, see Figure 3.3 and 3.4 about the numbering
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The naphthalene-based compound gossypol has long been known to exhibit
antimalarial and other biological activities. Previous studies have indicated that
compounds of this type target plasmodium falciparum lactate dehydrogenase
(pfLDH), an essential enzyme for energy generation within the parasite. Crystal
structures of the complexes formed by binding of to their target enzyme have been
used to delineate the molecular features likely to form the gossypol binding site.
Although this core pharmacophore-like molecule only exhibits low levels of
inhibitory activity, these molecular snapshots provide a rational basis for renewed
structure-based development of naphthalene-based compounds as anti-malarial
agents. The impact of the new gossypol glycosides on trypanosoma brucei parasites
has also been explored. Gossypol has been reported to inhibit certain oxidoreductases,
such as R-hydroxy acid and malate dehydrogenases in trypanosoma. Brucei, and
Kaminsky et al. reported that the EC50 value of gossypol in 24 hrs growth inhibition
test for three separate T. brucei strains was over 10 ppm (Kaminsky et al., 1989). In
our study, diglycosidic tetraacetates (compound 7&8) have been shown to be most
effective against trypanosome brucei with significantly lower LD50s values (2.21 µM
and 2.44µM respectively) compared with unmodified gossypol and gossypol
diglycosides 10 and 11(Table 1 & Figure 3.18). The fact that the hemiacetal form in
7 and 8 might probably block themselves from the Schiff base formation with proteins
maybe contribute to their potent inhibition effect on trypanosoma brucei cell growth,
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Gossypol

7

8

10

11

LD50

36.90

2.21

2.44

>100

72.60

±SD

10.24

0.09

0.21

------

1.04

Table I. LD50 (µM) values of gossypol (G), gossypol diglycosidic tetraacetate (7&8),
gossypol diglycoside (10&11) to trypanosoma brucei cells
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Figure 3.18 .The LD50 (µM) values of gossypol, gossypol diglycosidic tetraacetates,
gossypol diglycosides to trypanosoma brucei cells. G stands for Gossypol, GS1 for 7,
GS2 for 8, GS1' for 10, GS2' for 11, see Figure 3.3 and 3.4 about the numbering
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The attenuation of gossypol’s impact against trypanosomes is possible partially due
to the gossypol protein interactions. In addition, acetyl residues have also been proved
to play an essential role in the anti-trypanosomal activity from our results, the
non-acetyl gossypol diglycosides (10&11) which are present as dialdehyde form yield
weaker inhibition comparable to unmodified gossypol (72.6µM and >100µM), which
is consistent with our hypothesis. Flitter et al. also reported that some specific
vaccines containing acetyl residues could elicit reverse biological response (Moe et al.,
2009).

3.5 Conclusion
In conclusion, novel glycosidic gossypol analogues were obtained and fully
characterized for the first time. The studies of inhibition of cancer cell lines and the
cytotoxic effect indicated that the gossypol diglycosidic tetraacetate 8 possessed the
lowest cytotoxic effect compared to other gossypol glycosides. Moreover, 8 exhibited
strong anticancer as well as anti-trypanosomal activity. It shows that the diglycosidic
tetraacetate 8 can be possibly developed as a potential anticancer agent or
anti-trypanosomal agent. Further investigation is being carried out in our lab to
identify the mechanism of structure activity relationship responsible for the biological
activities.
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Figure A3. 1 The DEPT 135 0 spectra of 7
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Figure A3.2 The DEPT 900 spectra of 7
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Figure A3.3 1H NMR spectra of 8
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Figure A3.4 The DEPT 900 spectra of 8
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Figure A3.5 The DEPT 1350 spectra of 8
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(Figure A3.6-1)
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(Figure A3.6-2)
Figure A3.6 The 1D NOE spectra of 7 (A, B)
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(Figure A3.7-1)
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(Figure A3.7-2)
Figure A3.7 The 1D NOE spectra of 8
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Figure A3.8 The UV spectra of 7 (left) and 8 (right)

Figure A3.9 The HPLC spectra of 7(left) and 8 (right)
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Figure A3.10 The MS spectra of 10, m/z=[M+Na]+=865.2(Positive mode: top),
m/z=[M-H]-=841.5(Negative mode: bottom)
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Figure A3.11 The MS spectra of 11, m/z = [M-H]-=841.5(Negative mode)

Figure A3.12 The HPLC and UV spectra of 10

Figure A3.13 The HPLC and UV spectra of 11
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Figure A3.14 The 13C NMR spectrum of 7
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CHAPTER 4

UNEXPECTED FORMATION OF N-METHYLFULLEROPYRROLIDINES
BY THE REACTION OF FULLERENE AND GOSSYPOL AND THEIR
BIOACTIVITIES

4.1 Abstract
Fullerene [60] reacted with 2, 2′-bis-(formyl-1, 6, 7 trihydroxy-5-isopropyl-3methylnaphthalene) (gossypol) in the presence of sarcosine through the Prato
reaction, this reaction resulted in some unexpected N-methylfulleropyrrolidines, and
different products in variable yield were obtained when choosing toluene or
chlorobenzene as reaction medium. These fulleropyrrolidines were fully characterized
via rigorous structure determination through multiple spectral experiments, which
included 1D NMR (1H NMR, 13C NMR, the DEPT), 2D NMR (HMQC, HMBC), UV,
FT-IR, HRMS, HPLC and X-ray crystallography. During the reaction, gossypol
decomposed into benzaldehyde which was successfully detected as a new
intermediate through GC–MS spectra, although the polyphenolic gossypol undergoes
decomposition under drastic conditions such as heat and high pressure and the
detailed composition have been studied, this new intermediate has never been
detected and reported.
Besides, in an in vitro assay of NO radical induced apoptosis in 3T3L1 cells for
the N-methylfulleropyrrolidines and pure fullerene, N-methylfulleropyrrolidine (the
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compound 7) and N-methyl-2, 2-dimethylfullerpyrrolidine (the compound 8) showed
dose dependent and stronger radical scavenging activities than the parent fullerene.
The study in this chapter enriched the chemistry of gossypol l and gave a hint to
illustrate the mechanism during the decomposition f gossypol.

4.2 Introduction
Buckminster fullerene also called bucky ball is a distinct state of carbon. They
were reported by Kroto et al. (1985; 1991) in the form of C60 molecules. Since then
there have been various studies for the utilization of this physically stable but
chemically reactive molecule. Applications of C60 in areas such as optical devices,
semiconductors, chemical sensors, catalysis and in the medical field have been
explored (Yadav et al., 2008). While among various potential properties of the parent
fullerene and fullerene derivatives, biomedicinal function might be one of the most
promising utilities (Hirsch et al., 1994; Jensen et al., 1996; Daros et al., 1999; Bolskar
et al., 2003; Zhou et al., 2001). The capability of C60 and its derivatives to scavenge

C60

C70

Figure 4.1 The molecule structures of fullerene [60], fullerene [70]
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free radicals enables them to be a potentially useful source of new chemotherapeutic
agents in the prevention or treatment of some chronic diseases, such as AIDS (HIV-1
protease inhibition) (Marcorin et al., 2000; Friedman et al., 1998; Zhu et al., 2003),
malignant tumors (Mashino et al., 2003), osteoporosis (Gonzalez et al., 2002;
Mirakyan et al., 2002; Yin et al., 2005; Yin et al., 2006) etc, fullerene and its
derivatives also possess neuroprotective, antibacterial and gene transfection
properties(Susanna et al., 2003). Moreover, it has been recognized that fullerenes are
one of the key building blocks for nanoscale materials, C60 has been considered as
interesting candidate for constructing nanoparticulate drug delivery systems that are
able to be loaded with various biofunctional agents for providing different
bioactivities (Maggini et al., 1993; Georgakilas et al., 2002).
Nanoparticle based drug delivery systems have considerable potential for
treatment of some certain diseases. The important technological advantages of
nanoparticles used as drug carriers are high stability, high carrier capacity, feasibility
of incorporation of both hydrophilic and hydrophobic substances, and feasibility of
variable routes of administration. Nanoparticles can also be designed to allow
controlled (sustained) drug release from the matrix. These properties of nanoparticles
enable improvement of drug bioavailability and reduction of the dosing frequency,
Nanoparticles for the purpose of drug delivery are defined as submicron colloidal
particles. This definition includes monolithic nanoparticles or nanospheres in which
the drug is adsorbed, dissolved, or dispersed throughout the matrix and nanocapsules
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in which the drug is confined to an aqueous or oily core surrounded by a shell-like
wall. Alternatively, the drug can be covalently attached to the surface or into the
matrix (Gelperina et al., 2005).
In our study, the original purpose is to synthesize a covalent bonded fullerene
gossypol conjugate through 1, 3-dipolar cycloaddition as the following Figure 4.2
and 4.3 shows.
The Prato reaction or 1, 3-dipolar cycloaddition which is the most versatile and
wildly used method to functionalize fullerene, there need an aldehyde group bearing
molecule, and an α-terminal amino acid and unsaturated compound, the pyrrolidine

RNH-CH2-COOH
+

R'
HC

R
HCR'

N

R
N
CH2

CH2

R'CH=O
R
HCR'

N

CH2

Azomethine ylide

Figure 4.2 The reaction of C60 with azomethine ylide through the Prato reaction
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HO

N

CHO
OH

HO

CH

CH3NHCH2CO2H

HO

2

C60

C60
OH

HO

gossypol

2

Figure 4.3 The reaction between gossypol and C60

like derivatives were obtained though a azomethine ylide as intermediate (Maggini et
al., 1993).
Some pioneering work has been initiated to make various functional fulleropyrrolidines, which are regarded as versatile building blocks for fullerene containing
functional molecules. As we mentioned before, gossypol, which is a polyphenolic
compound widely existing in members of the Malvaceae family and particularly rich
in cottonseed, has two aldehyde groups and possesses a wide spectrum of biological
activities such as contraceptive, antiviral, antiamoebic and antiprotozoan effects.
While gossypol displays toxicity to a few of system in mammals as we introduced in
the review in Chapter1, and gossypol is hydrophobic compound which to some extent
limit the bioavailability of gossypol. Some researchers reported that the aldehyde
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group could bind to proteins when it is consumed by human or animals. If the
fullerene based gossypol could be obtained through the 1, 3-cycloaddition and the
reactive aldehyde groups would be blocked and the lower toxicity was expected. In
addition, the fullerene residue is more lipophilic, so the designed nano-based gossypol
could become more lipophilic and maybe affect the way of administration and the
process of absorption, distribution, metabolism, and excretion. Gossypol is considered
suitable for making nanoparticlebased drug for its multiple bioactivities and chemical
reactivity of gossypol.
In this context, an attempt to synthesize a fullerene–gossypol hybrid was
conducted by 1, 3-dipolar addition, the Prato reaction. However, fulleropyrrolidines
rather

than the

expected

fullerene–gossypol hybrid

were

formed.

These

fulleropyrrolidines were fully characterized via rigorous structure determination
through multiple spectral experiments such as 1D NMR (1H NMR, 13C NMR, DEPT),
2D NMR (HMQC, HMBC), UV, FT-IR, HRMS, HPLC and X-ray crystallography. In
the course of synthesis and with the aid of gas chromatography–mass spectrometry
(GC–MS), we found that benzaldehyde was formed as a new reaction intermediate
from gossypol degradation upon heating in toluene. In 1930s, Adams and his
coworkers (1938; 1939) found that, under heating conditions, gossypol ethers
degraded into a reaction intermediate termed gossic acid, which had roughly half
molecule of gossypol. In addition, Clark and his coworkers (1928) found that formic
acid, acetic acid, n-butyric acid, as well as iso-butyric acid were formed as
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decomposition products during the reaction between gossypol and potassium
permanganate in sodium hydroxide solution. In the present study, benzaldehyde was
found for the first time to be an intermediate for gossypol reactions.

4.3 Experimental
4.3.1 Materials
Fullerene [60] (99.5%) was purchased from SES Research, Houston, TX, USA.
All organic solvents (HPLC grade) were distilled in vacuum in order to reduce the
content of dissolved oxygen or filtrated by 0.2micro PVDF membrane filter. Toluene,
chlorobenzene were purchase from Fisher Scientific, Pittsburgh, PA, USA. The
solvents

were

dehydrated

by distillation

in the

presence

of

CaH2.

1,

2-dichlorobenzene-d4 and chloroform-d was from Cambridge Isotope Laboratories,
Inc., MA, USA. Carbon disulfide (CS2, MW=76.14). Sarcosine (N-methylglycine,
C3H7NO2, MW=89.09) was from Alfa Company, MA, USA. Gossypol acetic acid
was isolated by Soxhlet extraction, 6-methoxygossypol and 6, 6-dimethoxygossypol
were provided by USDA-SRRC. Both methoxygossypol derivatives were 1:1 M
solvates of acetic acid. Like gossypol acetic acid (1:1), both methylated gossypols are
racemic. Sodium nitroprusside (SNP, Na2 [Fe(CN)5NO]·2H2O,MW= 261.92) was
from Sigma–Aldrich (Atlanta, GA). Heat-inactivated fetal bovine serum, fetal bovine
serum, and newborn calf serum were purchased from Hyclone Laboratories, Inc.
(Logan, UT). 3T3L1 fat cells were purchased from the American Type Culture
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Collection (ATCC) (Rockville, MD). The CellTiter96 Aqueous assay kitwas
purchased fromPromega, Madison, WI.
4.3.2 Instruments
4.3.2.1. X-ray analysis
The X-ray diffraction data were collected with graphite-monochromated Cu Ka
radiation (k = 0.71073 A°) on a Rigaku AFC8S diffractometer with a Mercury CCD
detector at 193 K. The structure was solved by direct methods, and refined using
full-matrix least-squares techniques with the program SHELXTL.
4.3.2.2 NMR experimental
1D and 2D NMR spectra were acquired using a Bruker AV-500 spectrometer or
JEOL operating at 300 MHz (for 1H NMR). Data processing was carried out by the
Bruker XWINNMR 3.50 program. (See Chapter2 for detail)
4.3.2.3 FT-IR analysis
The transmission FT-IR spectra were obtained using a Perkin Elmer 2000 FT-IR
spectrometer. (See Chapter2 for detail)
4.3.2.4 Mass spectral analysis
Mass spectra were acquired on Q-Tof micro (Waters) with direct injection
through capLC to nanospray in negative ion mode. MassLynx software drives the LC
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and autosamplerand permits data collection in MS and MS/MS modes. The
ProteinLynx Globe Server 2.1.5 (PLGS) software performed the data analysis. (See
Chapter2 for detail)
4.3.3 Synthesis of fulleropyrrolidines
4.3.3.1 Extraction of gossypol from cottonseed
Dry the Soxhlet apparatus at 105°C to constant weight, add the crushed cotton
seed (1.5kg) to the cloth container and seal to prevent sample loss during the
extraction. Place several boiling chips into a clean, dry receiving flask (5L container).
Pour 3L solvent into the dry receiving flask and insert the cloth container and install
the apparatus as Figure4.5 shown. Heat at reflux for 48hrs, periodically check the

Figure 4.4 The gossypol extraction apparatus
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reflux rate and adjust the heating rate to give solvent exchanges every three hours, we
use petroleum ether to remove fatty acid and proteins and use acetone to extract
gossypol.

When the extraction time is complete, place the receiver flask on the

rotary evaporator and remove the solvent under vacuum. Pure gossypol (22.5g, yield:
1.5%) which was confirmed by NMR spectra was obtained by repeated
recrystallization from acetone solution by adding 50% glacial acetic acid.
4.3.3.2 Synthesis and spectral data of N-methyl-2-phenylfulleropyrrolidine
(compound 12) and N-methylfulleropyrrolidine (compound 13)
A sample of C60 (100 mg, 0.139 mmol) was dissolved in dry toluene (30 ml) and
then the solution of gossypol (80.36 mg, 0.139 mmol) in DMSO (3 ml) as well as an
equivalent amount of sarcosine (12.37 mg, 0.139 mmol) were added. After 5 min of
nitrogen flushing, the mixture was heated at 110 oC for 18 hrs (Figure 4.5). The
product of N-methyl-2-phenylfulleropyrrolidine (12, 32.4 mg, 27.3%) was purified

Figure 4.5 The reaction apparatus
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by flash chromatography (chlorobenzene/hexane, 5/3). The subsequent elution with
chlorobenzene/ methanol (100/1) afforded N-methylfulleropyrrolidine (13, 8.6 mg,
7.3%). Noticeably, 43% amount of C60 was recovered in this reaction.
Spectral data of 12: 1H NMR (300 MHz, ODCB-d4) 2.76 (s, 3H, N–CH3), 4.14
(d, 1H, one of proton of CH2 in pyrrolic structure), 4.86 (d, 1H, the other proton of
CH2 in pyrrolic structure), 4.88 (s, 1H, CH in pyrrolic structure), 7.30 (m, 1H, Ph-H),
7.42 (t, 2H, Ph-H), 7.86 (s, 2H, Ph-H); 13C NMR (75 MHz, ODCB-d4) 39.68,
(N–CH3), 69.05 (sp3 C of C60), 69.95 (CH2 in pyrrolic structure), 77.22 (sp3 C of
C60), 83.52 (CH in pyrrolic structure), 135.72, 135.91, 136.51, 136.80, 137.37,
139.28, 139.72, 139.99, 140.02, 141.30, 141.51, 141.71, 141.75, 141.84, 141.86,
141.94, 142.00, 142.14, 142.17, 142.31, 142.35, 142.47, 142.78, 142.92, 144.18,
144.25, 144.37, 144.53, 144.92, 145.01, 145.06, 145.11, 145.17, 145.33, 145.37,
145.40, 145.56, 145.72, 145.89, 145.98, 146.02, 146.05, 146.07, 146.35, 146.66,
147.08, 153.37, 153.55, 153.96, 156.35;
IR m/cm-1 (KBr): 3437, 2921, 2779, 1637, 1429, 1182, 1107, 699, 575, 526;
ESI m/z: 854 [M+1] +. Anal. calcd for C69H11N: C, 97.06%; H, 1.30%; N,
1.64%. Found: C, 97.46%; H, 1.29%; N, 1.50%.
Spectral data of 13: 1H NMR (300 MHz, CDCl3) 3.04 (s, 3H, N–CH3), 4.44 (s,
4H, four proton of CH2 in pyrrolic structure), 13C NMR (75 MHz, ODCB-d4) 41.12
(N–CH3), 69.98 (two CH2 in pyrrolic structure), 71.22 (two sp3 C of C60), 131.98,
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132.84, 136.19, 139.95, 141.66, 141.87, 142.09, 142.39, 142.87, 144.37, 145.06,
145.21, 145.51, 145.84, 145.95, 146.03, 147.09, 154.97;
IR m/cm-1 (KBr): 3447, 2851, 1384, 1338, 1229, 1158, 1069, 797, 737, 596,
573, 552, 525.
4.3.3.3 Synthesis and spectral data of N-methyl-2, 2-dimethylfulleropyrrolidine
(compound 14)
A sample of C60 (60 mg, 0.0834 mmol) was dissolved in dry chlorobenzene (30
ml) and then the solution of gossypol (48 mg, 0.0834 mmol) in DMSO (3 ml) as well
as two equivalents amount of sarcosine (24.74 mg, 0.167 mmol) were added. After 5
min of nitrogen flushing, the mixture was heated at 120 oC for 18 h. The reaction
products were purified by flash chromatography (chlorobenzene/methanol, 100/1, vol)
to afford the compounds 14 (11.3 mg, 27.3%) and 2 (7.4 mg, 18.5%).
Spectra data of 14: 1H NMR (300 MHz, CS2–CDCl3) 1.95 (s, 6H, C–(CH3)2), 2.87 (s,
3H, N–CH3), 4.56 (d, 2H, CH2 in pyrrolic structure), 13C NMR (75 MHz,
CS2–CDCl3) 22.85, (two carbons of C–(CH3)2), 34.20 (N–CH3), 65.73 (CH2 in
pyrrolic structure), 68.89 (quartary carbon attached to N), 69.59 (sp3 C of C60), 77.73
(sp 3 C of C60), 136.26, 136.71, 139.92, 140.34, 141.84, 141.99, 142.09, 142.23,
142.32, 142.54, 142.77, 144.67, 144.72, 145.35, 145.41, 145.52, 145.80, 146.16,
146.35, 146.39, 146.65, 154.61, 156.33;

127

IR m/cm-1 (KBr): 3434.81, 2924.88, 2963.09, 1384.90, 1157.13, 1097.91, 1021.96,
990.75, 802.95, 736.43, 640.90, 573.80, 554.15, 525.76;
HRMS (ESI) m/z calcd for C65H11N, 805.09; found, 806.09 [M+1] +.
4.3.4 Bioactivity assay
In the selected in vitro assay of NO radical induced apoptosis in 3T3L1 cells, the
3T3L1 preadipose cells in RPMI supple-mented with 5% fetal bovine serum (FBS)
were seeded into a 96-well tissue culture plate (105 cells/well, 80 µl/well), prior to
chemical treatment. They were allowed to attach for 24 h. After that, 10 µl SNP (0.3
mg/ml) in medium was added into each well except the control group. In this test, the
cell viability in 0.3 mg/ml SNP solution was 63.46% compared to the blank. The cells
were then treated with a defined concentration (0–100 µg/ml) of the test compounds
(C60, 12, 13, 14), which were finely dispersed in medium for another 24 hrs. Then 20
µl /well of combined MTS/PMS solution were added. After keeping in an incubator in
a humidified, 5% CO2 atmosphere at 37 oC for 3 hrs, the supernatant (80 µl /well)
was transferred to another 96-well tissue culture plate, which was recorded under the
absorbance at 490 nm using an EL800 Bio-Tek microplate reader. Each treatment was
measured in three replicates to give the value in the mean ± SD.

4.4 Results and discussion
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C60 reacts with gossypol in the presence of sarcosine in toluene to produce
N-methyl-2-phenylfulleropyrrolidine (12) and N-methylfulleropyrrolidine (13) in
27% and 7.3% yield, respectively (Figure 4.6). Their structures were determined by
MS, FT-IR, 1H, 13C NMR, DEPT (distortionless enhancement by polarization
transfer) and HMQC spectroscopy [(1H-detected) heteronuclear multiple-bond
quantum coherence correlation]. The 1H NMR spectrum of 12 showed that it was not
a simple hybrid of fullerene and gossypol because of the missing proton signals of
–OH, –CH3 and –CH(CH3)2 groups of gossypol and unexpected appearance of proton
signals in the aromatic area. The 13C NMR spectrum of compound 12 (see Appendix
III) shows five signals in saturated carbon area. The HMQC spectra showed that the
proton resonance at 2.76 ppm correlated to the carbon resonance at 39.68 ppm and the
proton resonance at 4.14 ppm as well as 4.86 ppm correlated to the same carbon
resonance at 69.95 ppm. At the same time, the proton signal at 4.88 ppm correlated to
the carbon resonance at 83.52 ppm. Its 13C NMR and DEPT spectra demonstrated
two sp3 carbons of fullerene (69.05 ppm, 77.22 ppm), one secondary carbon (69.95
ppm), one tertiary carbon (83.52 ppm), and a methyl group attached to the nitrogen
atom (39.68 ppm). Noticeably, fifty signals in the unsaturated carbon area indicated
that 12 had

C1

symmetry.

Compound 12

was finally figured out as

N-methyl-2-phenylfulleropyrrolidine which was further confirmed by its X-ray
crystallographic structure (Figure 4.8), the method of single crystal culture and the
detailed data of the its X-ray crystallographic structure of compound 12 refer the
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Appenda III in the end of this chapter. The 1H NMR spectra (300 MHz, CDCl3) of
compound 13 showed a singlet at 3.04 ppm for the protons in the methyl group
attached to the nitrogen atom and a singlet at 4.44 ppm for the four protons of the

PhCH3
N CH3

reflux, 18h
12

+
+

G1
+

N CH3

CH3-NH-CH2-COOH

13

CHOOH

OH CHO

HO

OH
OH

G1=Gossypol, HO

Figure 4.6 The reaction of fullerene and gossypol in toluene
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Compound 13

Compound 12

Figure 4.7 The flash column and TLC separation of the reaction mixture, flash
column chromatography (PhCl:hexane=5:3,silica gel 200-300)
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methylene group in the pyrrolic structure. The 13C NMR spectra of 13 (see Appenda
III) showed only 18 signals in the unsaturated carbon area, suggesting a more
symmetrical C2v structure. In contrast, the 1H NMR of compound 14 displayed the
proton signals of methyl group attached to the nitrogen atom, two methyl groups
attached to the quartary carbon as well as a methylene group in the pyrrolic structure
calibrated as 3:6:2, and the 13C NMR spectra of 14 in CS2 and CDCl3 showed 6
signals in saturated area. In addition, the DEPT 90o spectra did not show any peaks,
which indicated no methenyl group in the molecule of 14. Furthermore, the spectra of
DEPT 135 o displayed two positive signals for the carbon of the methyl group attached
to the nitrogen atom at 22.85 ppm and two equivalent carbons of the methyl groups
attached to the quartary carbon in the pyrrolic ring at 34.20 ppm, respectively.
Combining the mass spectra and IR data, the compound 14 was finally characterized
as

N-methyl-2,

2-dimethyl

fulleropyrrolidine.

After

slow

evaporation

of

chlorobenzene at room temperature, black single crystals of the compound 12 that
were of X-ray crystallographic quality were obtained with shiny faces that were
brown in transmitting light. The obtained X-ray structure (Figure4.8) at 273 K is in
agreement with that from the NMR derived assignments.
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Figure 4.8 ORTEP drawing of N-methyl-2-phenylfulleropyrrolidine (12) with
thermal ellipsoids plotted at 50% probability. Selected bond lengths (A°) and angles
(deg): N(1)–C(3) 1.158(10); N(1)–C(2) 1.445(8); N(1)–C(1) 1.464(9); C(3)–C(4)
1.497(9); C(3)–C(10) 1.602(10); C(4)–C(9) 1.339(9); C(4)–C(5) 1.360(9); C(5)–C(6)
.376(10); C(6)–C(7) 1.416(10); C(7)–C(8) 1.344(10); C(8)–C(9) 1.399(10);
C(10)–C(11) 1.503(8); C(10)–C(18) 1.786(10); C(11)–C(21) 1.635(12); C(11)–C(12)
1.772(10); C(12)–C(13) 1.365(9); C(13)–C(14) 1.374(8); C(14)–C(15) 1.225(14).
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PhCl
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N CH3

+

13

G1

+

+
N CH3

CH3-NH-CH2-COOH
G1=Gossypol

14

Figure 4.9 The reaction of fullerene and gossypol in chlorobenzene

134

Compound 14

C60

Figure 4.10 The flash column separation of the reaction mixture, flash column
chromatography (PhCH3: methanol=5:1, silica gel 200-300)

There is no reaction at room temperature for both reactions shown in Figures 4.6
and 4.9, and the reactants are UV light stable too. The reactant mixture remained
unchanged after being exposed to UV light irradiation at 254 nm for 17 hrs. When the
reaction was carried out in toluene, compounds 12 and 13 were both the main
products within 18 hrs, while the latter became the dominant product after 18 hrs.
However, when using chlorobenzene, compounds 13 and 14 were obtained, but no
compound 12 was detected. The mechanism of this unusual transformation is unclear
by a lack of understanding of the exact nature of gossypol involved in the process.
However, a plausible mechanism for this reaction in toluene was attributed to the
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formation of a new reaction intermediate, benzaldehyde, which was derived from
gossypol. The intermediate benzaldehyde from gossypol reacted with fullerene under
such reaction conditions resulting in these fulleropyrrolidines, just like a common
1,3-dipolar addition reaction in the presence of amino acid. The formation of
benzaldehyde from gossypol degradation was only detected in toluene, but not in
chlorobenzene. In order to gain a deeper insight of the reaction process and elucidate
the reaction mechanism, gossypol was heated without C60 in different solvents
(toluene and chlorobenzene). Two portions of 10 ml gossypol solution (dissolved in
toluene and chlorobenzene, respectively) at same concentration (1 mg/ml) were added
into two vials which were sealed and then heated at 110 oC for 12 hrs. After the
thermal treatment, the gossypol solution using toluene as solvent displayed a deep
orange color that was significantly different from its original yellow color, while the
gossypol chlorobenzene solution remained the same bright yellow color as before,
which demonstrated that the reaction mechanism: the reaction results tell us there
exist intermediate product benzaldehyde during degration of gossypol using toluene
as solvent. Gossypol had undergone a much more dramatic decomposition in toluene
than in chlorobenzene. Additionally, benzaldehyde was detected by GC–MS (Figure
4.12) in the toluene solution but not in the chlorobenzene solution. The possibility that
the intermediate aldehyde derived from toluene was eliminated since it was not
detected in pure toluene under the same heating condition.
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(A) (continued)

(B) (Continued)
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(C)
Figure 4.11 (A) The HPLC chromatography of toluene: Rt= 5.3 min; (B) The HPLC
chromatography of benzaldehyde: Rt=7.0 min; (C) The HPLC chromatography of the
reaction mixture of toluene and gossypol after refluxing overnight

In addition, when gossypolone which was prepared by the Shirley’s method
(1965), 6-methoxygossypol and 6, 6-dimethoxy-gossypol reacted with C60 under the
same conditions, only compound 13 was obtained (Figure 4.13). Further bioassay
showed that these N-methylfulleropyrrolidines exhibited dose-dependent growth
protection from nitric oxide (NO) radical induced apoptosis to 3T3L1 cells (Figure
4.14). Sodium nitroprusside (SNP) is usually considered to be a precursor of nitric
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Figure 4.12 The GC-MS spectra for mixture of toluene and gossypol after refluxing
overnight
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Figure 4.13 The reaction of gossypol and gossypolone, 6-methoxy gossypol and 6,
6′-dimethoxygossypol respectively in toluene
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cell damage protection of fullerene derivatives
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Figure 4.14 Cell damage induced by NO free radical protection of C60, and
compounds 12, 13, 14

oxide radical, which is a short-lived free radical generated endogenously, exerts
influence on a number of functions, including vasodilation, neurotransmission,
synaptic plasticity and memory in the central nervous system. Overproduction of NO
can lead to toxicity, e.g. DNA fragmentation, cell damage and neuronal cell death
(Dawson et al., 1992). Among the C60 and N-methylfulleropyrrolidines, compounds
13 and 14 exhibited stronger free radical scavenging activity than the parent fullerene

in preventing NO induced damage, especially by the compound 14. These results
indicate that the pyrrolic structure in these fullerene derivatives has a tendency to
increase the bioactivity.
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4. 5 Conclusions

In conclusion, three unexpected N-methylfulleropyrrolidines were obtained from
the reaction of fullerene and gossypol, and characterized by 1D, 2D NMR, FT-IR, MS
and X-ray crystallography. In toluene, the N-methyl-2-phenylfulleropyrrolidine
(compound 12 ) and N-methylfulleropyrrolidine (compound 13) were obtained, while
the compound 13 and N-methyl-2, 2-dimethylfulleropyrrolidine (compound 14) were
formed in chlorobenzene. On the other hand, the rigorous structure characterization of
these products as well as the new intermediate detection provided better
understanding of gossypol’s degradation reaction behavior. Moreover, the bioassay
for the cell damage protection demonstrated that the pyrrolic structure in the
fulleropyrrolidines might have contributed enhanced radical scavenging activity
evaluated in vitro.
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Figure A4.1 The IR spectrum of 12
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Figure A4.2 The IR spectrum of 13
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Figure A4.3 The IR spectrum of 14
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Figure A4.4 The IR spectrum of C60
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Figure A4.5 The IR spectrum of C60, 12, 13, 14 (P0:C60; P1:12; P2:13 ; P3:14)
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Figure A4.6 The 1HNMR spectrum of 12(300MHz, ODCB-d4)
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Figure A4.7 The 13CNMR spectrum of 12 ((75MHz, ODCB-d4)
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Figure A4.8 The HMQC spectrum for 12(300MHz, ODCB-d4)
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Figure A4.9 The ESI-MS spectrum of 12
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Figure A4.10 The DEPT 90°spectrum for 12 (300MHz, ODCB-d4)
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Figure A4.11 The DEPT 135°spectrum for 12 (300MHz, ODCB-d4)
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Figure A4.12 The 1HNMR spectrum of 13 (300MHz, CS2-CDCl3)
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Figure A4.13 The 13CNMR spectrum of 13(300MHz, ODCB-d 4)
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Figure A4.14 The 1HNMR spectrum of 14 (300MHz, CS2-CDCl3)
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Figure A4.15 The 13CNMR spectrum of 14(75MHz, CS2-CDCl3)
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Figure A4.16 The 13CNMR spectrum of 14 (75MHz, CS2-CDCl3), from
130ppm-160ppm
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Figure A4.17 The ESI-MS spectrum of 14
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Figure A4.18 The ORTEP drawing of compound 12 with thermal ellipsoids plotted at
50% probability.

Bond precision:
Cell:

C-C = 0.0110 A

a=10.074(2)
alpha=90
Temperature: 158 K
Volume
Space group
Hall group
Moiety formula
Sum formula
Mr
Dx,g cm-3
Z

Wavelength=0.71073

b=9.974(2)
beta=92.67(3)

Calculated
3979.4(14)
P 21/c
-P 2ybc
C69 H11 N, C6 H5 Cl
C75 H16 Cl N
966.34
1.613
4
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c=39.648(8)
gamma=90
Reported
3979.5(14)
P21/c
?
?
C75 H16 Cl N
966.34
1.613
4

Mu (mm-1)
F000
F000'
h,k,lmax
Nref
Tmin,Tmax
Tmin'

0.158
1960.0
1961.35
12,11,47
7060
0.959,0.984
0.942

0.158
1960.0
12,11,47
6771

Correction method= Not given
Data completeness= Ratio = 0.959
R(reflections)= 0.1991( 4095)
S = 2.430

Theta(max)= 25.110
wR2(reflections)= 0.4688( 6771)

Npar= 694

*There are several methods for single crystal culture such like sublimate,
co-crystallization, etc, but the most simplest and the most practical ones are slow
evaporation, diffusion in liquid phase, diffusion in gas phase, we recommend the
optimal amount of the sample for single crystal culture is 5-15mg, crystal
nucleus could not formed in extreme diluted solution, while when the mother liquor is
over concentrated, quick crystallization process results in bad crystals. In our
experiment, the pretreatments of the samples include purification using preparative
TLC and filtration through a cotton ball which is placed in a pipette, we found cotton
balls better than a filtration paper in crystal culture. There are several solvents we use
for this single crystal such as benzene, chlorobenzene, chloroform, dichloro methane
or solvent mixture systems (good solvent and poor solvent in different proportion
1:2-1:4). We set five tubes for each solvent system, all the tubes were sealed with
paprafilm and punched with tiny holes and were put on a stable position for a few
days.
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CHAPTER 5

SUMMARY

In this thesis, methylation, glycosylation and nanoconjugate reactions of the
natural product-gossypol were studied. The bioactivity assays of the gossypol
derivatives such as antioxidant, antidiabetic, anticancer, antitrypanosomal activities
were explored. The gossypol derivatives including gossypol ethers, apogossypol,
gossypolone, gossypol glycosides, unexpected N-methylfulleropyrrolidines products
obtained from the gossypol based nanoconjugate reactions as well as related gossypol
derivatives were synthesized and fully characterized by NMR, MS, FT-IR, UV
spectrometry, HPLC and X-ray crystallography.
Firstly, hexamethyl and tetramethyl ethers of gossypol were synthesized,
particularly, existence of four tautomers of gossypol tetramethyl ethers were
chromatographically separated and confirmed with the assistance of NMR method.
Gossypol exhibited the strongest antioxidant activity due to the high number of
hydroxyl groups, while its ethers only remained partial antioxidant activity because of
their conjugated naphthalene structure preserved in the derivatives. It was found that
the anticancer activity of gossypol and its methylated ethers depended on the degree
of methylation level of gossypol, the lower level of methylation the molecule
undergoes, the higher antioxidant activity it held. Furthermore, the result of
alpha-amylase inhibitory activities of gossypol and its methylated ethers showed that
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the gossypol's methylated ethers were the alpha-amylase inhibitors, while gossypol
was the alpha-amylase activator.
Secondly, novel glycosidic gossypol analogues were obtained by the
ultrasound-assisted

reaction

of

potassium

salt

of

gossypol

with

3,

4,

6-tetra-O-acetyl-α-D-glucopyranosyl bromide under phase transfer catalytic condition.
The evaluation of anticancer, antitrypanosomal activities as well as cytotoxicity of
those novel glycosidic gossypol derivatives implied that 6, 7'-gossypol diglycosidic
tetraacetate (compound 8) could be developed into a potential pharmaceutical
candidate in the treatment of cancer since it exhibited powerful cancer cells inhibition
with significantly low cytotoxicity. In addition, 7, 7'-gossypol diglycosidic
tetraacetate (compound 7) and 6, 7'- gossypol diglycosidic tetraacetate (compound 8)
possess strong antitrypanosomal activity with LD50 value low to 2.12 and 2.44 µM
respectively.
Finally, gossypol reacted with fullerene [60] in the presence of sarcosine through
the Prato reaction, resulting in some unexpected N-methylfulleropyrrolidines, and
different products in variable yield were obtained when choosing toluene or
chlorobenzene as reaction medium. During the reaction, gossypol decomposed into
benzaldehyde which was successfully detected as a new intermediate through GC-MS
for the first time which enriches the research of gossypol decomposition reaction. In
an in vitro assay of NO radical induced apoptosis in 3T3L1 cells for the N-methyl-2,
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2-dimethylfulleropyrrolidine (compound 14) showed dose dependent and stronger
radical scavenging activities than the parent fullerene.
The natural product-gossypol possess potential bioactivities in many aspects and
certain toxicity to some extent, the chemical modification of gossypol is an efficient
way to convert this two edge weapon to the more favorable direction, the prospective
work about chemical reactions of gossypol can be sulfonation, halogenation,
complexation etc, taking place in different reactive points of the gossypol molecule,
future work will be focus on the quantitative structure-activity relationship (QSAR) of
those novel gossypol derivatives and the mechanism to the molecular level of
digestion, absorption, metabolism and excretion in biosystems.
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